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The EGR family of transcription factors is known to be activated in cells exposed to growth 
factors in a variety of tissues.  The overall structure of the family is highly conserved while the 
amino acid sequence can be quite diverse allowing for a wide array of DNA recognition 
sequences.  Through homology modeling it is possible to reproduce the structure of the DNA 
binding domain of EGR proteins, which consists of three zinc fingers.  It has also been 
determined through molecular dynamic simulations that most side chains within the domain reach 
an equilibrium state.  However, residues that are essential for DNA binding are seen throughout 
the simulation as not reaching an equilibrium state, but constantly sampling available 
conformational space.  Furthermore, through cluster analysis the three recognition residues in 
each zinc finger are found to have side chain conformations that are optimal for DNA 
recognition.  These studies help to show a possible mechanism for zinc finger recognition of 
DNA and create homology modeled proteins that are able to be used in protein – DNA interaction 
prediction. 
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Understanding interactions between proteins and DNA has become a major area of 
research in biology within the past few years.  Furthermore, the challenges of predicting these 
interactions have lured both computational biologists and bioinformaticists into joining the 
expedition.  By understanding the general mechanism for protein – DNA binding, it is possible to 
further understand cell regulation and develop more specific pharmaceuticals for existing 
diseases.   
Focusing on specific families of proteins has allowed for advancements in the field, 
specifically with the early growth response factor (EGR) family.  This family of transcription 
factors has proved useful due to the fact that it is highly conserved and extensively studied.   It 
has been implicated in a diverse set of cellular processes including cell growth, differentiation, 
and apoptosis (Gashler and Sukhatme 1995).  The EGR family of transcription factors is within 
the class of immediate early genes (IEGs) which are the group of genes directly activated by 
extracellular signals.  Immediate early genes have been referred to as the “gateway to the 
genomic response” as they control the regulation of downstream genes, with two subclasses: 
effector and regulatory genes (Davis et al. 2003).  EGR proteins respond to mitogens, 
differentiation stimuli, tissue injury and signals from neuron excitation (Gashler and Sukhatme 
1995).  Mitogens are the dominant form of extracellular signals for EGR protein induction and 
also cause the quickest reaction in EGR production.   
All members of the EGR family contain two or three zinc finger domains which are used 
in conjunction with one another to recognize specific DNA sequences (Benos et al. 2002).  Each 
zinc finger recognizes approximately 5 bases within the DNA strand, and has an overlap in the 
recognition of bases due to coordination between the other fingers in the protein (Palliard et al. 
2004).  Christy and Nathans first described EGR proteins in 1989 as containing three repeated 
zinc finger domains, and they hypothesized that collectively these domains worked as 
transcription factors to recognize a specific DNA sequence.  The gene they describe, zif268, is 
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widely expressed in mouse tissues and is also known by the names NGF-1A, egr-1, and Krox-24.  
The consensus DNA sequence for zinc finger binding of zif268 is GGGCGGCG TG .  A high 
affinity for guanine in DNA recognition is specific to this family. 
Each zinc finger in the EGR family of transcription factors is of the type zf-C2H2, where 
‘zf’ stands for zinc finger and C2H2 represents the 2 conserved cysteine and 2 conserved 
histidine residues.  The zf-C2H2 domain has a consensus pattern of: ‘x-C-x(1-5)-C-x(12)-H-x(3-
6)-H’ (Hulo et al. 2004).  The ‘X’ in the pattern stands for any amino acid with the amount of 
repeating units in parenthesis.  Structural stability in the domain is provided by the four conserved 
residues working together to coordinate a zinc ion along with a conserved aromatic ring located 4 
amino acids away from the second cysteine residue.  Figure 1 shows the zf-C2H2 domain in both 
a two- and three-dimensional manner, as well as the details of how the four conserved residues 
coordinate the zinc ion.  Each zinc finger domain includes one α-helix and two β-strands.  The α-
helix is inserted into the major groove of the DNA double helix and is responsible for recognizing 
          (a)                                     (b)   
                 
 
Figure 1. Patterns of zf-C2H2 domain.  (a) The two dimensional representation of the zf-
C2H2 domain.  The four conserved residues that coordinate the zinc ion are shown in the 
center of the domain. The yellow ‘X’ four residues away from the second cysteine residue is 
also a conserved aromatic ring essential to the stability of the domain. Adapted from Prosite 
figure.  (b)  Three dimensional representation of the zinc finger C2H2 domain.  The amino 
acid and zinc coloration is the same as in (a). 
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at most 5 nucleic acids.  The two conserved histidine residues responsible for coordinating the 
zinc ion are located towards the C-terminal of the α-helix pointing away from the DNA, as can be 
seen in Figure 2.     
The EGR family of proteins has a set method of DNA recognition that is coordinated 
between the three zinc fingers, with each finger specifically recognizing three nucleotides.   Each 
domain has three key residues for interaction with DNA, the negative one position, the third 
position and the sixth position in the α-helix, and can be seen in Figure 3.   DNA recognition is 
specific to the residues that are located within the three key residues, and the given recognition 
sequence can be changed by mutating the protein binding region (Palliard et al. 2004).  Secondary 
interactions also occur within the 
binding region through water 
molecules.  These secondary 
interactions help to overlap the 
recognition of DNA between the zinc 
finger domains and involve additional 
residues located within the α-helix.  
When secondary interactions are 
included, each domain can recognize 
between four and seven nucleotides.   
The proteins that include the 
classic zinc finger domain are quite 
diverse.  According to Pfam version 
17.0 (Bateman et al. 2004), there are a 
total of 32,784 different protein 
domains that have been identified with 
Figure 2.  Representative Structure of the EGR 
Family of Transcription Factors.   Seen here is the 
EGR protein from Mus musculus (PDB identifier: 
1A1F).  The DNA structure is shown in orange, with the 
backbone outlined.  Each of the zinc finger domains is 
highlighted, starting with the N-terminus domain in 
yellow, followed by the second domain in blue, and the 
C-terminus domain in red.  The four conserved amino 
acids, two cysteine and two histidine, can be seen 
coordinating the space-filled zinc atom.  The conserved 
histidine residues are located within the α-helix, pointing 
away from the DNA chain.  As can be seen from the 
figure, each of the zinc finger domains is inserted into 
the major groove of the DNA.  Each domain overlaps 
the recognized bases with the subsequent domain.   
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a zf-C2H2 domain; 1,390 of those sequences are from humans and 1,085 are from Mus musculus.  
The various zf-C2H2 protein sequences are broken up into 235 different architectures, including 
the ‘zf-C2H2, zf-C2H2, zf-C2H2’ architecture that includes the EGR family of transcription 
factors.  This architecture has 723 members of which 128 are from humans.  There are 5 
recognized human EGR proteins; however there may potentially be an additional 26 human 
proteins that could belong to the EGR family, determined by sequence length and proximity of zf-
C2H2 domains to one another.  The remaining human sequences do not exhibit similarity to the 
EGR family of proteins.   
Although proteins with zinc finger domains are highly studied, there are few structures 
available relative to the number of sequences that contain the domain.  There are a total of 43 
structures in the Protein 
Data Bank (PDB) with 
resolved zinc finger 
domains as of October 
2005.  A preliminary 
BLASTp search of the 
PDB yielded a total of 9 
to 11 structures that 
would be eligible for use 
as a template for structure 
prediction for the EGR 
family.  Of these possible 
templates, one is of 
human origin and the 
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Figure 3. EGR Protein binding motif.  (a) DNA binding motif 
for zif268, the representative for the EGR family. (b) DNA 
binding motif for a zif268 variant recognizing the TATA box.    
The key interactions are shown for each domain with the solid 
arrows  representing hydrogen bonds.  Adapted from a figure by 
Palliard et al. 2004. 
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musculus.  Four of the mouse structures are variants of the wild-type EGR family proteins.  With 
the lack of structure data for this large family of proteins, structure prediction is necessary for 
being able to predict the potential interactions with DNA.  
The main goals of this project consist of investigating the diversity of the EGR family in 
humans including basic bioinformatics analysis, carrying out homology modeling between 
resolved structures and known human EGR proteins and analyzing the structures to determine if  
protein – DNA interactions are possible.   
 
Methods 
This project has been working towards creating a pseudo-pipeline of programs that is 
able to take the DNA binding region of an EGR protein and be able to accurately determine a 
template for homology modeling in hopes of finding the most likely amino acid conformations to 
determine a structure for use in protein – DNA interaction prediction.  While this process is not 
completely automated, significant progress has been made towards reducing the amount of 
human intervention in the process.  There are numerous points in the following methods which 
need to be examined for quality purposes.  Figure 4 shows the general flow of the methods from 
an amino acid sequence to a clustered protein structure. 
 
EGR Family Analysis 
Before beginning with homology modeling of the EGR family of transcription factors, it 
was first necessary to gain an understanding of the diversity its members.  Members of the family 
were gathered through the Pfam database, starting with all proteins that have a zinc finger domain 
of the C2H2 type (Pfam ID: PF00096).  It was determined through conversing with Dr. Takis 
Benos of the University of Pittsburgh that the proteins of interest for the purpose of the project 
were only the human zinc finger proteins with either two or three zf-C2H2 domains.  To gain an 
understanding of the diversity of the individual domains, the domains were split apart from the  
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protein and a multiple sequence alignment was performed using ClustalW (Thompson et al. 
1994).  The alignment was performed using an opening gap penalty of 4.0, a gap extension  
penalty of 10.0 and the PAM matrix series.  The goal of the alignment was to align the conserved 
cysteine and histidine residues in the zinc finger.   
 
Template Determination 
The first step involved in this project was to determine the proper structure(s) to use as a 
homology modeling template(s) for a 
given query sequence.  With so few 
predetermined structures for the EGR 
family, a combination of multiple 
template structures may be needed to 
determine an accurate predicted 
structure.  Basic analysis of EGR 
sequences were done using the results 
from BLASTp against the PDB database, 
and performing multiple sequence 
alignments to determine the best possible 
alignment and template (Altschul et al. 
1997).    
 
Structure Modeling 
After the proper template for the 
query sequence was determined, the 
program Consensus was used to create 
 
 
Figure 4. Flowchart of Methods.  There are three 
groups of methods used: template determination, 
structure modeling, and structural analysis.  
Template determination, shown in blue, is the first 
three steps and is vital to having an accurate 
prediction.  Structure modeling, shown in red, is the 
next three steps and is where all of the primary data 
are generated.  Finally, the analysis is shown in 
purple and is broken into two different parts: 
analysis against the crystal structure and clustering 




Figure 5.  Figures of Isoleucine and 
Alanine.  The structures of these amino 
acids are only similar through the C-β 
atom, and thus Isoleucine can be modeled 
only through its C-β leaving C-γ1, C-γ2, 
and C-δ not in the model. 
the homology model (Prasad et al. 2003).  Although 
multiple templates may be beneficial during 
homology modeling, Consensus can only 
accommodate one structural template.  Instead, 
Consensus uses five different methods to create an 
alignment between the template structure and the 
sequence to be modeled with the structure being 
determined through threading algorithms. Not only 
does Consensus perform its own sequence 
alignment between the template and query, it also 
predicts the accuracy of the secondary structure assignment for the alignment allowing the user to 
easily assess the prediction.  Although Consensus selectively removes regions of dissimilarity and 
splits loosely connected domains to minimize potential misalignments, the zinc finger domains of 
the EGR proteins were not broken apart during the homology modeling process due to the high 
similarity between the models and the templates.   
The structure that was returned from Consensus was incomplete in respect to the side 
chains of the amino acids.  Since threading algorithms are used, side chains for the query 
sequence can only be predicted in the model as much as they are in agreement with the template.  
For example, if an isoluecine from the query sequence is aligned with an alanine in the template, 
the predicted structure for isoleucine would contain the side chain through the Cβ atom, as that is 
where the structural similarity between the two concludes.  Figure 5 further demonstrates this 
point.  Thus, completion of the side chains must be performed to be able to use the structure in 
further analysis.  For this application, side chains were completed and minimized through the use 
of CHARMM (Brooks et al. 1983).  Most importantly, CHARMM added the necessary hydrogen 
atoms to the amino acids, which are required to be able to do molecular dynamic simulations.   
The three domains of each EGR protein were manually broken apart for the side chain 
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completion and molecular dynamic simulations.  The independent domains overlap one another 
by three residues. 
The final modeling of the EGR protein involved molecular dynamic (MD) simulations to 
allow for fluctuation of the individual amino acids.  According to Camacho, molecular dynamic 
simulations can help to predict native-like rotamer conformations of the side chains (2005).  
Proper prediction of side chain conformation is essential to predict interactions, whether they are 
between proteins or proteins and DNA.  If one side chain is modeled improperly the resulting 
prediction of interactions could be incorrect.     
Simulations are to be performed using GROMACS, in which the protein is simulated 
using the default settings (Lindahl et al., 2001).  The protein is solvated in a dodecahedral water 
layer where there is a minimum distance from the protein to the edge of the water layer.  The size 
of the water layer was varied, and the optimal water layer was found to be 1.75 angstroms when 
the simulation commences.  Throughout the simulation, the carbonyl carbon, carbonyl oxygen, 
and nitrogen atoms of the backbone are constrained to keep the protein in the general state that 
was predicted through homology modeling.  The simulation for each zinc finger domain of the 
protein lasted a total of 4.0 ns with each time step lasting 2 femtoseconds.  The first 0.2 ns are 
removed from the simulation data for equilibrium purposes.  Following the simulation, snapshots 
were taken every 2.5 ps recording structural information to be used for analysis of the simulation. 
 
Structure Analysis 
There were two different classes of structural analysis that have taken place: analysis 
against the crystal structure and analysis of the most highly sampled rotamer conformation.  
These two different forms of analysis are vital as this method is being verified using known 
structures for the query protein to have a measurement of the predictive abilities of the homology 
modeling and the molecular dynamic simulations.   
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The first form of analysis compared each amino acid for each snapshot of the MD 
simulation against the crystal structure.  Each amino acid was individually analyzed by 
computing the distance between each heavy atom in the predicted structure and the crystal 
structure, defined as the sum of the absolute value of the differences of each of the three 
dimensions.   Before the distance was calculated, the amino acids were aligned to minimize the 
fluctuations the protein may have encountered during the MD simulation.  To align the amino 
acids, the distance was calculated for each axis in space between the alpha carbons (Cα) and was 
subtracted from each atom in the predicted structure to align the two amino acids.  Figure 6 
further demonstrates this point visually.  The root mean square (RMS) was then calculated, with d 
being the distance between N pairs of structurally equivalent atoms.  Additionally, the RMS was 
computed a second time for arginine residues to account for the symmetry in the terminal atoms.  












     (Eq. 2) 
( )212111 zzyyxxd −+−+−=    (Eq. 1)  
Figure 6.  Alpha Carbon Centering.  (a)  Pictured are two unaligned glutamate 
residues, one from the crystal structure shown in magenta, and the other from the MD 
simulation shown in orange.  Computing the RMS between these two residues is going 
to return a value that is misleading. (b) The two residues are aligned, with the crystal 
structure still shown in magenta, and the modeled structure is shown in yellow.  Here the 
RMS is going to give much more insight into the difference between the two structures.  
(c) Shown is the difference between the unaligned and the aligned structure.   
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but in the case of arginine the two terminal atoms are both nitrogen, and are randomly assigned 
the designation of ‘NH1’ and ‘NH2’.  Thus when the terminal atoms were compared to the crystal 
structure it was also necessary to compare ‘NH1’ to ‘NH2’ and vice versa.   
The second form of analysis aimed to complete the structural prediction process by 
clustering the individual side chains of the modeled protein.  A neighbor clustering method was 
employed to gain general insight into the structure of a given amino acid.  Kozakov et al. have 
described a clustering method for amino acid side chains that is applicable to this project (2005).  
Through clustering, we were looking to determine the most frequently sampled conformation 
throughout the MD simulation.  This procedure relied on the calculation of the RMS for the 
heavy atoms in a side chain between pairs of time points.  The procedure for calculating the RMS 
in this step of the analysis was the same as comparing the simulated structures to the crystal 
structure.  The first 0.2 ns were dropped from the simulated data before clustering commenced to 
allow for equilibrium purposes. Approximately 1.16 * 106 RMS calculations were required to 
compare each snapshot to every other snapshot for one residue.  Each modeled protein has 
approximately 90 residues, equating to 1.04 * 108 RMS calculations.  Due to the magnitude of the 
RMS calculations required, three different clustering techniques were attempted throughout the 
course of this research, one technique used PERL, another used Java, and a third also used PERL 
but utilizing a different method. Between all three different techniques, conformations were 
clustered together if the RMS was found to be within a clustering radius of 0.75 angstroms.   
The first two methods of clustering are very similar, but were instantiated in different 
programming languages.  The clustering method was first developed using PERL, and is suitable 
for smaller data sets of approximately 400 models.  This program holds every coordinate of every 
atom for each model throughout the simulation in memory, and then stores the RMS between 
each residue.  Although it was memory intensive, the program was successful in clustering 
simulations of 1.0 ns in length, however when applied to a 4.0 ns simulation, the program quickly 
maximized memory usage, and took upwards of 24 to 36 hours to cluster one residue, which 
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would have equated to approximately three months to cluster one simulated protein.  This result 
was highly unsatisfactory.   
Next, a similar clustering algorithm was constructed in Java using the class structure and 
taking advantage of the hierarchical nature of object oriented programming.  The system 
developed had classes for models within a simulation, residues within a model, and atoms within 
a residue.  There was also a clustering class that applied the previously developed classes.  This 
system was slightly different in the fact that only a subset of residues were accessed and held in 
memory at one point in time to keep memory usage low.  The class method was also not ideal due 
to the fact that clustering still took approximately a week for one protein.   
The third method of analysis developed utilized a program that computes the RMS 
between two PDB files.  In the two previous clustering methods, a majority of the time was spent 
calculating the RMS, which was not done in an efficient method.  By computing the RMS 
externally from the clustering algorithm and storing the results in a file, the time it takes for 
computing the RMS and clustering is significantly reduced.  Computing the RMS was reduced to 
approximately one day per domain, and multiple domains were run simultaneously.  For each 
comparison, a RMS file was created, which was accessed in the clustering algorithm.  Following 
calculation of the RMS, the clustering program read in the RMS calculations, and clustered 
residues that were within 0.75Å radius of one another.   
 
Results 
EGR Family Analysis 
A multiple sequence alignment was performed between all of the human EGR proteins 
listed in the Pfam database.  A total of 719 domains were aligned encompassing a total of 287 
EGR proteins.  The alignment is a total length of 32 residues, with each domain being 23 residues 
in length.  By having a low gap opening penalty of 4 and a larger gap extension penalty of 10,  
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CLUSTAL W is able to align three of the four conserved residues: the two cysteine residues and 
the first histidine.  The fourth residue is the final histidine residue in the α-helix which is noted in 
the profile of the family as sometimes being replaced by a cysteine, which occurs in 2.2% of the 
zf-C2H2 domains.  These two residues are not seen as easily interchangeable by CLUSTAL W in 
the alignment procedure as cysteine is polar neutral and histidine is polar basic (Figure 7a).  
Additionally, the distance between the histidine residues can vary by a difference of four 
locations at the tail end of the domain.  Since there is variability in the location of the histidine, 
CLUSTAL W prefers to keep the end of the domain intact unless inserting a gap is more 
favorable than misaligning a residue (Figure 7b).  The full alignment can be seen in Appendix A.   
 
Homology Modeling 
The three structures under investigation are a C2H2 zinc finger protein, a C2H2 zinc 
finger variant, and a C2H2 designed zinc finger.  The C2H2 zinc finger protein (PDB 1AAY), 
was crystallized in 1997 with a 1.60 Å resolution and was chosen because of its sequence 
complementarities to the EGR family consensus (Elrod-Erickson et al., 1996).  The second 
(a) 
Z297B_HUMAN_428-450         YECN--ICAKRFMWRDS--FHRHVTS-C---- 
Q6ZN18_HUMAN_45-70          YNCCWDQCQACFNSSPD--LADHIRS-IH--- 
Q6ZN29_HUMAN_3-26           YQCKK--CNVVFPRIFD--LITHQKKQ-C--- 
                              *    *              :          
 
(b) 
HELI_HUMAN_140-162          FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q6ZMZ8_HUMAN_69-92          FHCDQ--CSYSCKRKDN--LNLH--KKLKH— 
FOG2_HUMAN_363-385          FRCN--HCHFGFQTQRE--LLQHQ--ELH--- 
Q9C0D4_HUMAN_982-1004       FKCW--FCGRLYEDQEE--WMSHGQR--H--- 
                              *    *              :          
 
Figure 7.  Sample Alignments from the Multiple Sequence Alignment of EGR Protein 
Domains.  (a) The misalignment between the final histidine and cysteine residues.  Although 
gaps are inserted into the sequence, if the gaps were removed, the domain would be aligned 
correctly in this instance.  (b) CLUSTAL W prefers to keep the carboxyl terminal of the 
domain together and places a priority in aligning the residues occurring before the final 
histidine. 
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structure, the C2H2 zinc finger variant (PDB 1G2D), was crystallized in 2000 with a 2.20 Å 
resolution and was chosen for its relatively high sequence identity with 1AAY and its divergence 
of the binding domain (Wolf et al., 2001).  These proteins have 79% sequence identity, but are 
only 14% identical in the DNA binding domains.   The final structure that was chosen for 
analysis, the C2H2 designed zinc finger (PDB 1MEY), was crystallized in 1996 at 2.20 Å 
resolution (Kim and Berg, 1996).  This protein has 49% identity with 1AAY, but unlike 1G2D, 
 
 
Figure 8.  Full Alignments of EGR proteins of interest. (a) Multiple sequence alignment 
of all EGR Proteins in use.  Domain 1 is outlined in blue, domain 2 in yellow, and domain 3 
in red. The DNA binding region is also highlighted for each domain. (b) Pairwise alignment 
between 1AAY and 1G2D.  The only difference between these two proteins lies in the DNA 
binding region.  (c) Pairwise alignment between 1AAY and 1MEY.  While there is more 
similarity in the DNA binding regions than between 1AAY and 1G2D at 86% there is only 
38% identity.  The overall identity and similarity is significantly lower at 49% and 77% 
respectively.  (d) Pairwise alignment between 1G2D and 1MEY.  Overall similarity between 
1G2D and 1MEY is 76%, while the identity is 42%, and the DNA binding domain is 76% 
similar and 29% identical.   
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1MEY has 38% identity to 1AAY in the binding domains.  1MEY was chosen to be modeled off 
of 1AAY due to the fact that similarity was slightly higher than that of 1MEY with 1G2D.  The 
pairwise and multiple sequence alignments of these domains can be found in Figure 8.  The three 
homology models that were constructed are the prediction of 1G2D with 1AAY as the template  
(GD-AA), 1AAY with 1G2D as the template (AA-GD), and 1MEY with 1AAY as the template 
(ME-AA).   
Each model utilizes the sequence from an EGR protein with a known structure and goes 
through the process of homology modeling, side chain completion, molecular dynamic 
simulations and clustering.  Upon completion of homology modeling, Consensus reports the 
strength of the alignment in terms of the compatibility of the five alignment processes, the 
secondary structure prediction, as well as two different structure predictions: the full structure 
prediction and the structure of the reliable regions.  For the purposes of this project the full 
structure prediction was used.  Output from Consensus for all three EGR modeled proteins can be 
found in Appendix B.   
For GD-AA, Consensus had a strong alignment between the target and template, but was 
only confident about the structure prediction for the first domain and the beginning half of the 
second domain.  This result is unexpected as the only regions of nonidentity are in the first seven 
amino acids of the α-helix for each domain.  It is possible that there is a shift in the secondary 
structure prediction, which could have caused the lower confidence.  However, the RMS between 
the backbones of GD-AA and 1G2D is 1.29 Å, which confers confidence to the structure 
prediction.   
The structure prediction of AA-GD is more favorable than the prediction of GD-AA.  
Although the alignments between 1G2D and 1AAY are the same in both homology models, 
Consensus was more confident in predicting AA-GD and this was seen in the selection status of 






Figure 9. Differences between Homology Models and Crystal Structures. (a) GD-AA (red) 
modeled against 1G2D.  (b) AA-GD (red) modeled against 1AAY (blue).  (c) ME-AA (red) 
modeled against 1MEY (blue).  Major differences in the homology models against the crystal 
structure is seen more prominanlty in the first and third domains, leftmost and rightmost 
domains respectively, particularly in the β-strands.  The second domains appear to have the best 
fit between all three represented figures.  
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eleven amino acids of the protein.  The RMS is also between the backbone of AA-GD and 1AAY 
is also very favorable at 1.29 Å.   
Although there is less similarity between 1AAY and 1MEY than between 1G2D and 
1AAY, Consensus has a very strong structural prediction for ME-AA.  Much like AA-GD, ME-
AA has a strong alignment throughout the whole protein, and Consensus is confident about the 
structural prediction through most of the model.  Unlike AA-GD, ME-AA does not have a 
confident secondary structure prediction at either the N or C terminals of the protein, lacking 
confidence for 9 and 10 amino acids respectively.  As the confidence is slightly lower for this 
model than the previous two, the RMS deviation is therefore slightly higher between ME-AA and 
1MEY at 1.35 Å.  The predicted models and crystal structures can be seen in Figure 9.   
The molecular dynamic simulations for each EGR protein zinc finger domain yields 
structure and energy information for each time step throughout the simulation.  To make the data 
more manageable, snapshots were taken every 2.5 ps creating 1600 total structures for the 4.0 ns 
simulation and were used for both types of analysis.  Initially, the simulations were lacking a 
layer of water large enough to allow for proper side chain fluctuations, which was made evident 
through examining the clustering results.  The initial water layer was 0.75 Å, which is insufficient 
for amino acids with larger side chains, for example arginine and lysine.  Figure 10 shows 
potential hydrogen bonding that was occurring in the second zinc finger domain in the GD-AA 
simulated structure. These results showed neighboring side chains hydrogen bonding to one 
another, which was unsubstantiated in the literature for the crystal structure. By expanding the 
water layer the side chains are given more flexibility and less chance to hydrogen bond with 






Figure 10.  Hydrogen Bonding in Initial 
Molecular Dynamic Simulation Data 
Clustering.   The aspartate and arginine residues 
from the second β-strand, shown in stick 
representation, have potential hydrogen bonds as 
they are located within 2.1Å.  The oxygen atom 
from the aspartate could hydrogen bond with 
either NH2 group in the arginine. 
Structure Analysis 
The structures resulting from the MD simulations were first analyzed against the 
corresponding crystal structure.  For each model there are nine different residues of interest, 
negative one position, third position and sixth position of the α-helix. 
The first model analyzed was GD-AA against the crystal structure for 1G2D.  The three 
positions in first domain exhibit three different characteristic states as can be seen in Figure 11.  
The first binding position is the negative one position, or the residue before the α-helix begins.  
The glutamine residue has very high 
fluctuation in the RMS throughout the 
course of the simulation.  There is no 
pattern within the fluctuations, but the 
residue does seem to be going between 
two different states, one state that is close 
to the crystal structure, approximately 
1.0Å difference, and another that is much 
further removed at approximately 2.5Å.   
The third position is occupied with an 
asparagine which resonates around and 
equilibrium point of 1.2Å difference from 
the crystal structure.  Most residues in the 
domain are expected to reach some sort of 
equilibrium state, which residue 21 
exemplifies.  The sixth position of the 
helix is inhabited by a threonine.  It is 
interesting that this residue clearly 
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fluctuates between two apparent states, one state existing around 0.3Å difference from the crystal 
structure and the other state having a 1.1Å difference. 
The residues in the second domain are not as interesting as the first domain, seen in 
Figure 12.  Residue 46, a glutamine, in the negative one position in the α-helix and is very similar 
to the glutamine in the -1 position of the first domain.  There seems to be fluctuation between two 
states, but it is not as distinct as other residues previously seen.  The first state is approximately 
1.0Å away from the crystal and the second state is approximately 2.25Å away, with the residue 
spending a significant amount of time in between the two states.  The third position in the helix 
does not yield much information as the residue is a glycine; the fluctuation seen in Figure 12b is 
between atoms located in the backbone of the structure.  The sixth position of the α-helix is also a 
glutamine residue, which has a similar RMS profile as residue 46.  The lower state fluctuates just 
below 1.0Å difference from the crystal structure and the higher state is situated around 2.25Å.  
Unlike residue 46, residue 52 does not spend much time in an intermediary state.   
The third domain is comprised of two threonine residues and an arginine residue, seen in 
Figure 13.  Residue 74 in negative one position of the α-helix has two very distinct states, the first 
fluctuating around 0.45Å and the second state existing at approximately 1.1Å difference from the 
crystal structure.  Residue 77, the threonine in the third position of the helix is in an equilibrium 
state for most of the simulation around 0.4Å difference from the crystal structure, but in the 
beginning and the end of the simulation it jumps to the higher state at 1.3Å difference.  The final 
residue of interest for GD-AA is residue 80, an arginine.  For the majority of the simulation, the 
residue is located between 3.0Å and 4.5Å away from the crystal structure.  While this residue has 
a more bulky side chain, it is not expected that it would be so far removed from the crystal 
structure.   
The residues of interest for the first domain of AA-GD are fairly far removed from the 
crystal structure as can be seen in Figure 14.  The negative one position fluctuates around 1.5Å 
away from the crystal structure with the higher state above 2.5Å difference.  Although the lowest 
19 






























































Figure 11.  Graphs of Domain 1 of GD-AA. All graphs are the RMS between the crystal 
structure of 1G2D against the MD simulation data of GD-AA against time in picoseconds.   
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Figure 12. Graphs of Domain 2 of GD-AA.  All graphs are the RMS between the crystal 
structure of 1G2D against the MD simulation data of GD-AA against time in picoseconds. 
21 
 































































Figure 13.  Graphs of Domain 3 of GD-AA.  All graphs are the RMS between the crystal 
structure of 1G2D against the MD simulation data of GD-AA against time in picoseconds. 
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state is removed from the crystal structure, it is more desirable than the results for the previous 
arginine residue, GD-AA domain 3 position 6.  Residue 21 vacillates between two states, and also 
spends time in an intermediary state.  The low state is approximately 0.5Å difference from the 
crystal structure, where the higher state is 1.1Å away.  The sixth position of the helix is occupied 
by another arginine residue, but unlike the arginine residue in the negative one position, this 
residue prefers to exist in a higher state around 2.5Å away from the crystal structure.  
The residues of the second domain seem to exist in states of equilibrium, except for the 
first residue as can be seen in Figure 15.  The arginine residue at the negative one position does 
not prefer to exist in any given state as it continually changes states.  Towards the end of the 
simulation, the residue goes through a series of gradual increases followed by a sharp decline in 
RMS.  This trend is interesting as the residue can quickly jump 3.0Å from a high state to a low 
state.  Residue 49, a histidine, highly prefers a state that is 1.25Å away from the crystal structure.  
This residue, like the threonine residues seen previously also jumps sharply into a higher state of 
2.5Å difference for brief periods of time.  The sixth position of the α-helix is a threonine and 
prefers a state that is 0.4Å away from the crystal structure.  The higher state resonates around 
1.2Å away from the crystal structure.   
Much like the first domain, the third domain has the same sequence of residues, and has 
very similar RMS profiles as seen in Figure 16.  The negative one position is an arginine residue 
and exists around 1.5Å away from the crystal structure.  The third position of the helix fluctuates 
between 0.5Å and 1.25Å away from the crystal structure.  The sixth position of the helix, an 
arginine residue, starts at a lower state around 1.5Å, and increases to a higher state around 2.75Å 
away from the crystal structure.  
The model of ME-AA introduces new residues of aspartate and lysine into the DNA 
binding positions.  The negative one position of first domain is a glutamine and is in a state of 
flux throughout the simulation not preferring one particular state, but the average RMS value  
23 


































































Figure 14. Graphs of Domain 1 of AA-GD.  All graphs are the RMS between the crystal 
structure of 1AAY against the MD simulation data of AA-GD against time in picoseconds. 
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Figure 15. Graphs of Domain 2 of AA-GD.  All graphs are the RMS between the crystal 
structure of 1AAY against the MD simulation data of AA-GD against time in picoseconds. 
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Figure 16. Graphs of Domain 3 of AA-GD.  All graphs are the RMS between the crystal 
structure of 1AAY against the MD simulation data of AA-GD against time in picoseconds. 
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throughout the simulation is 1.83Å difference from the crystal structure as can be seen in Figure 
17.  Residue 17, an asparagine, fluctuates around an RMS of 1.2Å.  The sixth position of the  
 α-helix is occupied by a lysine residue, which is functionally similar to an arginine and a strong 
residue for binding to molecules with negative charges.  Unlike other arginine residues that have 
been analyzed, the lysine here fluctuates between 1.0Å and 3.0Å difference from the crystal 
structure.   
The second domain is interesting in the way it is constructed and thus how it behaves 
within the simulation.  The negative one position is a neutrally charged glutamine which has a 
good deal of fluctuation, but is not uncommon when compared to other glutamine residues 
modeled and is seen in Figure 18.  The third position of the α-helix is an aspartate, which is 
negatively charged.  It fluctuates around the 1.0Å difference from the crystal structure.  What is 
interesting is that the negative residue is generally positioned between two positively charged 
residues, as domains 1 and 3 of AA-GD exhibit, not between a neutral and positively charged 
residue.  The lysine in position 6 of the α-helix resonates around 2.1Å difference from the crystal 
structure.   
The third domain of ME-AA has a unique RMS profile and can be seen in Figure 19.  
The negative one position arginine exists primarily around 1.5Å away from the crystal structure, 
but also fluctuates to a much higher state above 3.0Å.  The histidine residue in position 3 of the α-
helix fluctuates randomly between two states, one approximately at 1.0Å difference from the 
crystal structure, and the second state around 2.25Å difference.  The final residue of interest, an 
arginine in position 6 of the α-helix prefers a state that is over 4.0Å away from the crystal 
structure, but the RMS will periodically fall towards the observed state in the crystal.   
 
Clustering Results 
Clustering the side chains is the final step in determining the overall structure of the 
homology modeled protein.  Since we are trying to determine the structure that is closest to the 
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Figure 17. Graphs of Domain 1 of ME-AA.  All graphs are the RMS between the crystal 
structure of 1MEY against the MD simulation data of ME-AA against time in picoseconds. 
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Figure 18. Graphs of Domain 2 of ME-AA.  All graphs are the RMS between the crystal 
structure of 1MEY against the MD simulation data of ME-AA against time in picoseconds. 
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Figure 19. Graphs of Domain 3 for ME-AA.  All graphs are the RMS between the 
crystal structure of 1MEY against the MD simulation data of ME-AA against time in 
picoseconds. 
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crystal structure, the model for a given amino acid with the highest amount of neighbors through 
RMS analysis within a 0.75Å radius is selected.  The residues from the PDB files of various 
models are concatenated together.  The reason this is possible is due to the fact that the backbone 
is held constant throughout the simulation so the residues, when concatenated, form one 
connected protein.   
In creating one protein of three domains, the loop regions between domains are more 
difficult to reconstruct as there is duplication of residues between the different domains.  
Information on the individual domains for each homology model and the overlapping residues for 
each domain can be found in Appendix C.  For purpose of simplicity, the first residue of overlap 
between the two domains is captured from the N-terminal domain and the second residue of 
overlap is captured from the C-terminal domain.  For example, if the sequence for domain one is 
…GQKP and the sequence for domain two is QKPF… the glycine and glutamine from domain one 
and the lysine and phenylalanine from domain two are kept.  By selecting residues in this manner 
any terminal residue from each domain is discarded.  Additionally, the terminal residues 
generally have a high difference in the RMS from the crystal structure conferring additional 
support towards selecting non-terminal residues.  Examining the completed structures uses seven 
residues of interest per domain: the three residues used for DNA binding, the two conserved 
cysteine residues and two conserved histidine residues.   
The completed structure for GD-AA can be seen in Figure 20 as having fairly good 
conservation of the side chains from the crystal structure.  As can be seen in Figure 20a, the 
residues of interest are almost identical in structure to the crystal.  There is a rotation of the 
threonine in position 6 of the α-helix and the foreground cysteine (C1) is slightly rotated from the 
crystal, but still conforming to an architecture that is appropriate for binding the zinc ion.  Most 
of the residues that are seen in a conformation differing from the crystal structure lie within the β-
strands, which is expected as they are exposed to solvent.  The second domain, Figure 20b has a  
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Figure 20.  GD-AA Clustered Domain Results.  The homology model is shown in red with the 
crystal structure superimposed in blue with the conserved residues and DNA binding residues in 
stick form for (a), (b), and (c).  (a) Domain 1.  (b) Domain 2. (c) Domain 3.  (d) All domains for 
GD-AA concatenated together and colored by secondary structure: yellow is for a β-sheet, red for 
an α-helix, and cyan for the remaining residues.  Domain 1 is on the left. 
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Figure 21.  AA-GD Clustered Domain Results.  The homology model is shown in red with the 
crystal structure superimposed in blue with the conserved residues and DNA binding residues in 
stick form for (a), (b), and (c).  (a) Domain 1.  (b) Domain 2. (c) Domain 3.  (d) All domains for 
AA-GD concatenated together and colored by secondary structure: yellow is for a β-sheet, red for 
an α-helix, and cyan for the remaining residues.  Domain 1 is on the left. 
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Figure 22.  ME-AA Clustered Domain Results.  The homology model is shown in red with the 
crystal structure superimposed in blue with the conserved residues and DNA binding residues in 
stick form for (a), (b), and (c).  (a) Domain 1.  (b) Domain 2. (c) Domain 3.  (d) All domains for 
GD-AA concatenated together and colored by secondary structure: yellow is for a β-sheet, red for 
an α-helix, and cyan for the remaining residues.  Domain 1 is on the left. 
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less conserved structure than the first domain.  The DNA binding residues are highly similar to 
those in the crystal.  The third position of the α-helix cannot be seen due to the fact that the 
residue is glycine and the side chain is only a hydrogen atom.  The glutamine in the sixth position 
of the α-helix is rotated about the Cδ which puts the residue in a less desirable position to make 
contact with the DNA.  The third domain, Figure 20c, is the least desirable clustering formation 
for the protein.  Positions negative one and three of the α-helix are identical to the crystal, but the 
sixth position, an arginine, is rotated in the exact opposite direction of the crystal structure.  The 
RMS between these two residues is 3.62Å, and can be seen at time point 1287.5ps in Figure 13c. 
This is also the only of the domains in this structure to such a conflict between the conserved 
residues and the crystal structure.  The RMS and the time point for the residues of interest can be 
found in Table 1.  Both the cysteine (C1) in the background and the histidine (H2) in the 
foreground are rotated out of position and thus would not bind to the zinc atom if present.  The 
residues in the β-strands have much higher similarity to the crystal structure than the residues in 
either domain one or two.  A full table of RMS versus the crystal structure and time point for each 
residue within each domain can be found in Appendix D.  The complete model for GD-AA can 
be seen in Figure 20d having the β-strands only recognized in the first domain, which is the only 
domain that did not have the β-strands recognized after homology modeling (Figure 9a).   
Table 1.  Residues of Interest for GD-AA.   Listed for each domain is the time in which the 
residue was found and the RMS difference from the crystal structure.   
Domain 1 Domain 2 Domain 3 
Residue Time (ps) RMS Residue Time (ps) RMS Residue Time (ps) RMS 
C1 1820 1.08 C1 2432.5 0.45 C1 485 0.95 
C2 815 0.91 C2 325 1.26 C2 2010 0.49 
H1 1320 1.23 H1 2105 0.64 H1 1072.5 0.99 
H2 3302.5 1.18 H2 2885 1.24 H2 1665 2.80 
Helix -1 1120 0.97 Helix -1 377.5 0.86 Helix -1 2927.5 0.39 
Helix 3 2622.5 0.25 Helix 3 3382.5 1.14 Helix 3 2820 0.71 
Helix 6 1352.5 0.84 Helix 6 1605 1.25 Helix 6 515 3.62 
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The completed structure for AA-GD is slightly more disorganized than the completed 
structure for GD-AA.  The first domain, Figure 21a, does not show much similarity between the 
residues of interest and the crystal structure.  Although the arginine (position negative one) and 
the glutamate (position three) in the α-helix are quite similar to the crystal structure, the arginine 
in the sixth position is removed from crystal and bent inward towards the middle of the domain. 
The RMS between this residue and the crystal is 2.18Å.  Additionally, the conserved residues are 
not in favorable positions to coordinate a zinc ion.  The cysteine residues are angled away from 
one another, and the second histidine is turned down away from the crystal.  The RMS and time 
positions for the AA-GD can be found in Table 2.  The second domain, Figure 21b, is more 
ordered than the first domain.  The DNA binding residues in this domain oriented in a similar 
manner to the crystal structure with a slight difference in the positioning of the alpha carbon.  The 
only residues with positions that could be of concern are the C1 and H2 residues, which are both 
angled in a different manner than the crystal structure but in relative position to continue to 
coordinate a zinc ion.  The quality of the third domain lied between the first and second domains.  
The arginine (position negative one) and glutamate (position three) are in line with the crystal 
structure.  Once again, the arginine in the sixth position is turned inward towards the middle of 
the domain, leaving it in a difficult, but not impossible position for binding to DNA.  The RMS 
between the crystal and the clustered arginine residue is 1.55Å, which is low for this residue.  In 
Table 2.  Residues of Interest for AA-GD.   Listed for each domain is the time in which the 
residue was found and the RMS difference from the crystal structure.   
Domain 1 Domain 2 Domain 3 
Residue Time (ps) RMS Residue Time (ps) RMS Residue Time (ps) RMS 
C1 1095 0.94 C1 3792.5 1.07 C1 2592.5 0.87 
C2 280 2.05 C2 2437.5 0.49 C2 1410 0.84 
H1 882.5 1.77 H1 3847.5 1.52 H1 1117.5 1.25 
H2 2850 1.27 H2 2490 1.44 H2 655 2.84 
Helix -1 3102.5 1.13 Helix -1 2970 2.3 Helix -1 3402.5 1.39 
Helix 3 237.5 0.97 Helix 3 1087.5 1.27 Helix 3 2592.5 1.07 
Helix 6 1585 2.18 Helix 6 837.5 0.67 Helix 6 1415 1.55 
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Table 3.  Residues of Interest for ME-AA.   Listed for each domain is the time in which the 
residue was found and the RMS difference from the crystal structure.   
Domain 1 Domain 2 Domain 3 
Residue Time (ps) RMS Residue Time (ps) RMS Residue Time (ps) RMS 
C1 2385 0.5 C1 3605 0.64 C1 1707.5 0.6 
C2 3412.5 1.25 C2 1627.5 0.62 C2 2287.5 0.98 
H1 2847.5 0.49 H1 1412.5 0.67 H1 1265 0.93 
H2 1170 2.3 H2 1665 2.22 H2 660 1.88 
Helix -1 735 1.18 Helix -1 1320 0.71 Helix -1 2680 1.98 
Helix 3 2420 1.11 Helix 3 3735 1.07 Helix 3 2262.5 2.08 
Helix 6 3075 2.21 Helix 6 957.5 2.4 Helix 6 2005 4.51 
 
addition, both cysteine residues are angled away from one another, and the H2 residue is once 
again angled downwards.  
The completed structure for ME-AA has good structural preservation of the conserved 
residues as can be seen in Figure 22.  The first domain, Figure 22a, is conserved in the residues of 
interest except for position six of the α-helix, a lysine residue.  The lysine has a kink in the side 
chain near the beta carbon and is directed away from the supposed location of the DNA and has 
an RMS of 2.21Å against the crystal structure.  The second domain is similar to the first domain, 
except that the lysine in the sixth position of the α-helix is rotated about the beta-carbon to 
produce a side chain that is directed away from the location of the DNA with an RMS difference 
of 1.34Å difference from the crystal.  The third domain is slightly more chaotic in terms of the 
side chains of interest on the α-helix.   All three residues on the α-helix are not aligned with the 
crystal structure.  Detailed RMS descriptions can be found in Table 3.  All three of the residues 
are directed away from where the DNA would be located within the structure.  The conserved 
residues also have more fluctuation from the crystal structure that the other two domains, but are 
still oriented properly for zinc coordination.   
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Discussion 
Protein Structure Quality 
The structures of the final state of the clustered proteins are favorably aligned with the 
respective crystal structure.  When looking at the whole DNA binding region of the protein, the 
final structures exhibit RMS values that are desirable for the purpose of protein – DNA 
interaction prediction (Table 4).  The structures have much better RMS scores in between the 
backbone than the initial structures from homology modeling through Consensus.  Given that the 
RMS scores between all atoms within the models is around 1.7Å for each completed structure, 
there is confidence that these structures are of sound quality, but that there is some difference 
between the structures.  There may possibly be regions within the protein that are more dissimilar 
than other regions that can contribute to the increased RMS score.  Suspect areas are the loop 
regions between the domains, the loop region between the β-strands as well as the N and C 
terminals, as the homology modeling process ranked those regions as not having confidence in 
the prediction.  Differences can be visualized by referring back to Figure 9.   
 
Protein – DNA Interaction 
Although the completed proteins were not used in protein – DNA interaction prediction 
programs, it is still possible to observe potential interactions between the protein domains and the 
DNA present in the crystal structures.  By superimposing the DNA from the crystal structure onto 
Table 4. RMS values between completed models and the crystal structure.  Three different 
RMS calculations were made between a given crystal structure and completed model: between 
all atoms (amino acids), between C-α atoms, and between atoms in the backbone.  
 
RMS  1G2D vs. GD-AA 1AAY vs. AA-GD 1MEY vs. ME-AA
Amino Acids 1.68 Å 1.75 Å 1.70 Å 
C-α 0.52 Å 0.59 Å 0.60 Å 
Backbone 0.57Å 0.63Å 0.66Å 
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the completed structure of 
the homology model 
insight can be gained as to 
the probability of the 
protein making the 
necessary DNA 
interactions for binding.  
The completed structure for 
GD-AA is the best in terms 
of potential protein – DNA 
interactions (Figure 23).  
As a generalization, the 
negative one residue for all 
three domains has very 
strong interaction potential.  
Although the exact 
orientation is not ideal, the 
distance for interaction is in 
the scope needed for short 
range forces to take effect, 
less than 3 Å, in two of the 
three domains.   The first 
domain was the only one of 
the three to have the key 










Figure 23. Potential Protein - DNA Interactions for GD-
AA.  The DNA helix from the crystal structure for 1G2D was 
superimposed upon the completed structure for GD-AA.  For 
each figure the three residues in the α-helix are the -1, 3 and 6 
positions from top to bottom.  (a) Domain 1: Residues Q, N, 
and T.  (b) Domain 2: Residues Q, G (not pictured), Q.  (c) 
Domain 3: Residues T, T, R. 
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manner to create a possible 
interaction between the 
protein and the DNA.  The 
second and third domains are 
each missing an interaction.  
Domain two has the second 
residue as a glycine, which 
will not have a side chain to 
make a viable interaction, 
and the arginine in the third 
domain is oriented away 
from the DNA and thus no 
interaction is possible in this 
state. 
The structure for 
AA-GD has more possible 
interactions between the key 
residues and DNA than the 
previous structure of GD-
AA.  In this model, each 
domain has at least three 
possible interactions 
between the protein and 
DNA due to the orientation 









Figure 24. Potential Protein DNA Interactions for AA-GD.  
The DNA helix from the crystal structure for 1AAY was 
superimposed upon the completed structure for AA-GD.  For 
each figure the three residues in the α-helix are the -1, 3 and 6 
positions from top to bottom.  (a) Domain 1: Residues R, E and 
R.  (b) Domain 2: Residues R, H and T. (c) Domain 3: 
Residues R, E and R. 
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24).  The first domain has four 
potential interactions, with the first 
residue, an arginine, potentially 
interacting with two different bases 
in the DNA.  Each NH2 group of 
the arginine could make contact 
with the DNA.  Both of these 
interactions are more favorable than 
either of the two interactions for the 
third and sixth residues in the α-
helix, which are no closer than 4 Å 
to the DNA.  The second domain 
has each residue making contact with only one base, but the arginine in the negative one position 
is not interacting with the expected nucleotide.  The arginine is actually interacting with the 
guanine that the arginine in the sixth position of the α-helix in domain one is interacting, but on 
different atoms.  Interestingly, the two residues do not conflict with one another as would be 
expected since the two domains were modeled independent of one another (Figure 25).  Both the 
histidine and threonine are in favorable orientations to make the proper interactions.  While there 
is potential for making correct contact with the DNA for domain three, the distance of the side 
chains is not close enough to create hydrogen bonds or short range forces.   
The model of ME-AA has some interesting side chain conformations that complicate the 
binding of DNA.  ME-AA is the only structure that contains lysine residues in the key residues 
for binding to DNA.  All three domains for position six of the α-helix do not have a desirable 
conformation for binding to DNA in the proper and experimentally defined manner (Figure 26).   
For positions negative one and three in the α-helix in domain one, the orientation of the residues 
allows for potential interaction between the protein and DNA.  The lysine in position six is 
 
Figure 25.  Favorable Coordination of a Guanine by 
Residues in Two Domains.  The arginine from domain 
one is shown in red, and the arginine from domain two 
is shown in blue.  Although both residues are 
coordinating the same nucleotide, a guanine, they are 
interacting with different areas of the nucleotide. 
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skipping a nucleotide and 
interacting with the next 
nucleotide, an adenine, 
which is also being 
coordinated by the 
glutamine in position 
negative one in domain 
two.  The interactions on 
the adenine nucleotide are 
unfavorable due to the 
fact that the two arginine 
residues are attempting to 
occupy the same space 
(Figure 27a). The 
aspartate residue in 
domain two can have two 
possible interactions with 
same nucleotide, both in 
an advantageous 
orientation.  Once again, 
the lysine residue in 
domain two is positioned 
so that it is skipping a 
nucleotide, however the 










Figure 26. Potential Protein DNA Interactions for ME-AA.  
The DNA helix from the crystal structure for 1MEY was 
superimposed upon the completed structure for ME-AA.  For 
each figure the three residues in the α-helix are the -1, 3 and 6 
positions from top to bottom.  (a) Domain 1: Residues Q, N and 
K.  (b) Domain 2: Residues Q, D and K. (c) Domain 3: Residues 
R, H and R. 
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positioned allows for there to be no conflict in the interactions between the arginine in the 
negative one position and the DNA (Figure 27b).  The histidine in position three of domain three 
is not properly oriented to make a strong interaction with the DNA, but is within proximity to 
have both short and long range interactions.  The arginine in position six is not in a desirable 
conformation for binding to the DNA.  
Through close examination of the individual amino acids with respect to the nucleotides 
available, one can deduce that these structures are of sufficient quality to be able to perform 
protein – DNA interaction prediction algorithms.  Some of the residues discussed will need to be 
further examined in terms of the clustering results to find a better orientation, but to do so in an 
automated fashion would require the need for a robust algorithm for scoring clusters.  
Additionally, the DNA shown in these examples has been slightly distorted due to the fact that it 
originated from a crystal structure with a bound EGR protein, thus precise measurements are 




     
Figure 27.  Favorable and Unfavorable DNA Interactions within ME-AA.  (a) 
Unfavorable DNA interactions between a lysine (red) in domain one and a glutamine (blue) in 
domain two.  Both residues are attempting to interact with the same atom in the adenine and 
are occupying the same space.  (b) Favorable interactions with a lysine (red) in domain two 
and an arginine (blue) in domain three.   
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Protein – DNA Proposed Binding Mechanism  
The residues of interest from analysis against the crystal structure shed light into a 
possible mechanism for EGR proteins binding to DNA.  An EGR protein will not bind to DNA in 
the absence of zinc ions (Huang and Adamson 1993).  Until the point of binding, the structure of 
the protein is able to fluctuate and is seen throughout the MD simulation.  Through analysis of the 
simulations, certain residues have sparked heightened interest, specifically position six in the 
alpha helix.  Generally occupied by an arginine or lysine, position six is the only residue in the 
helix that consistently has a highly sampled state that is removed from the state of the crystal 
structure.  Additionally, the negative one position of the α-helix appears to fluctuate between two 
states throughout the simulation while taking time to sample the available space in between.  The 
third position of the α-helix is the one residue that tends to reach an equilibrium state and is 
generally an amino acid with a smaller side chain.   
It is possible that the information gathered on the states of the positions of the individual 
side chains could be related to the binding mechanism of EGR proteins, which is still yet to be 
empirically determined.  One possible mechanism that comes to light from this research is that 
the third position of the α-helix remains steady, while the negative one position of the α-helix 
samples the conformational space.  When the negative one position residue finds a desirable 
ligand it would rotate to a position to bring the third position of the α-helix closer to the DNA and 
increase the binding potential.  After that point, the sixth position of the helix would come into 
play and reach out to make the final interaction between the protein and the ligand, in this case 
double stranded DNA.   
There are many possible sources that could undermine the binding mechanism 
hypothesis.  The current method for analyzing the predicted structure of homology models is 
through RMS analysis, which has been criticized as being a measure not specific enough to yield 
in-depth information about the differences in structure.  Referring back to the graphs in Figures 
11 – 19, calculating the RMS is sufficient to tell how much difference there is between two 
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different states, but is not specific enough to be able to cluster the data on this information alone.  
Because the comparison in these graphs is against a steady state can there be information gained.  
RMS analysis is also used in the cluster determination for the completed structures of the 
proteins.  Here each time step is compared to every other time step for a given residue, and the 
time step with the highest amount of neighbors is reported and used in the structure of the 
completed protein.  Since RMS is not being used in a conventional hierarchical or non-
hierarchical clustering method, some of the reservations in using RMS as a means of determining 
structural information can be circumvented. 
Another source of concern stems from the neighbor clustering method instantiated in 
finding the best structure to make the completed structure.  Although the neighbor clustering 
algorithm reports all possible clusters, there is no straightforward way to identify markedly 
different clusters of a given residue.  It is possible to manually search through the high ranking 
clusters to find disparate clusters, but that is neither time efficient or able to be automated.  It is 
not guaranteed that the second or third highest ranking cluster is any different than the highest 
ranking cluster, since clusters are not distinct, non-overlapping sets.  This problem presents itself 
when looking at residues with a high amount of clusters accommodating less than a majority of 
the time steps but receiving similar amounts of neighbors.   
There are different approaches that could have been taken for clustering the side chains of 
the amino acids.  One way would have been to analyze the side chains against a rotamer library 
using RMS, and then using the rotamer with the highest amount of similar structures in the final 
structure reported (Kimura et al. 2001).  Another method would be to find the centroid for each 
side chain in a given residue and use hierarchical clustering methods in three-dimensional space 
to find the largest cluster within a given radius.  The disadvantage of this clustering method 
would be that valuable information about the side chain and the direction that it is facing would 
be lost due to reduction of dimensionality.  To alleviate the hindrance in the previous method, one 
could find the centroid of the last carbon in the side chain and any atoms extending beyond that 
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point and perform hierarchical clustering.  The advantage to this method would be that the subject 
that is of highest concern, the location of the tip of the side chain, would be forefront 
consideration of this method.  Ultimately, the atoms of the side chain would be neglected, but are 
of little concern since they are not interacting with the DNA.   
 
Future Research 
There are many areas of this project that can be further expanded in addition to ideas 
previously mentioned. There are two other areas for improvement within the current method for 
predicting the structure of EGR proteins.  The first improvement would be to make the method 
completely automated so that any user interested in EGR proteins would be able to create their 
own homology model and perform MD simulations.  Automating the procedure would be labor 
intensive as there are steps in the method that at this point in time require human interaction and 
require making knowledge-based decisions.  The second major area for improvement would be to 
develop a scoring function for addressing the quality of a homology model, and the completed 
structure after the simulation and clustering is complete.  A scoring algorithm would also be 
beneficial in the clustering process, potentially ranking rotamers seen throughout the simulation.  
Residues with a more energetically favorable state would appear higher in the list of clustered 
residues, thus not relying solely on the RMS calculation between structures.   
The next step for the completed predicted structure for zinc finger proteins would involve 
the use of a derivative of the ClusPro program, initially developed by Comeau et al. for predicting 
interactions between proteins (2004).  ClusPro uses two unbound structures and performs 
automated rigid body docking, and ranks the results based upon clustering of the resolved 
conformations on the evaluation of the properties of free energy, electrostatic and desolvation 
calculations.  Since this method uses two unbound structures it can also be applied to predict 
protein – DNA interactions, which is under development in the Camacho laboratory.  The initial 
clustered result for GD-AA with a 0.75Å water layer was tested to see if protein – DNA 
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interactions could be predicted.  The structures for the protein domains were predicted to a degree 
that they were able to pick up the experimentally proven interactions between 1G2D and the 
given DNA sequence.   
Aside from predicting protein – DNA interactions, there are many more experiments that 
can be performed using MD simulations.  Since we have MD simulation results for the homology 
modeled proteins without the presence of ions or DNA, the next step would be to add these 
incrementally to see how the protein reacts to the new conditions.  One starting point would be to 
add a zinc ion into each of the zinc finger domains.  It would also be advantageous to simulate the 
protein in the presence of DNA or a negatively charged object representing DNA both with and 
without zinc ion to see how the protein thus reacts.  Another interesting simulation would be with 
all three domains together, and allow for the backbone to be unconstrained in the loop regions 
between the zinc finger domains.   
 
Conclusion 
By exploring the EGR family of transcription factors there have been many insights 
gained into structure prediction for this specific family.  Since the EGR family is one of the 
largest families of transcription factors, the method developed can easily be used for any of the 
proteins within the family.  Using molecular dynamic simulations on singular domains yields a 
final clustered protein with side chains that have near-native conformations.  By analyzing the 
results and superimposing a DNA helix one can infer information about potential protein – DNA 
interactions before performing actual interaction algorithms.  Analyzing the completed domains 
before using interaction algorithms can help determine if there are residues that should be further 
explored.  By looking at the results, and the analysis against the crystal structure, a hypothesis for 
EGR proteins binding to DNA can be surmised: the negative one position of the α-helix is 
responsible for initial contact with the DNA, and the other key residues have interactions that are 
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Appendix A – Multiple Sequence Alignment of EGR Protein Domains 
 
Q69BL7_HUMAN_146-168        FQCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q69BM3_HUMAN_112-134        FQCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q69BM4_HUMAN_145-167        FQCNQ--CGASFTQKGN--LLRH--IKLH--- 
AIOL_HUMAN_146-168          FQCNQ--CGASFTQKGN--LLRH--IKLH--- 
IKAR_HUMAN_145-167          FQCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q6PQC6_HUMAN_114-136        FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q6PQD0_HUMAN_114-136        FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q6PQC8_HUMAN_140-162        FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q96JP3_HUMAN_147-169        FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q9H2S9_HUMAN_85-107         FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
HELI_HUMAN_140-162          FHCNQ--CGASFTQKGN--LLRH--IKLH--- 
Q6ZMZ8_HUMAN_69-92          FHCDQ--CSYSCKRKDN--LNLH--KKLKH-- 
Q5VWB8_HUMAN_446-469        FKCPS--CPLLFAQKRT--MLEH--LKNTH-- 
Q9H937_HUMAN_446-469        FKCPS--CPLLFAQKRT--MLEH--LKNTH-- 
Q68DQ8_HUMAN_858-881        FKCPS--CPLLFAQKRT--MLEH--LKNTH-- 
ZN592_HUMAN_892-915         FKCPE--CPLLFVQKPE--LMQH--VKSTH-- 
Q6MZM6_HUMAN_434-457        TICKI--CELSFETEHV--LLQH--MKDNH-- 
Q6N043_HUMAN_388-411        TICKI--CELSFETEHV--LLQH--MKDNH-- 
Q9H740_HUMAN_224-247        TICKI--CELSFETEHV--LLQH--MKDNH-- 
Q9HCI8_HUMAN_404-427        TICKI--CELSFETEHV--LLQH--MKDNH-- 
Q6N085_HUMAN_388-411        TICKI--CELSFETEHV--LLQH--MKDNH-- 
Q9NXS0_HUMAN_92-115         TICKI--CELSFETEHV--LLQH--MKDNH-- 
PRDM6_HUMAN_570-595         FKCER--CERSFTQATQ--LSRH--QRMPNEC 
Q8NEI5_HUMAN_266-288        FKCHL--CDRCFGQQTN--LDRH--LKKH--- 
Q5T967_HUMAN_201-223        FSCSL--CSYTFAYRTQ--LERH--MTSH--- 
ZN469_HUMAN_237-259         FACSS--CNYTFAKKEQ--FDRH--MNKH--- 
Q86X64_HUMAN_2-24           FKCTV--CDYTAAQKPQ--LLRH--MEQH--- 
Q6ZN18_HUMAN_112-136        FKCVVGGCNASFASQGG--LARH--VPTH--- 
Q96BG3_HUMAN_120-144        FKCVVGGCNASFASQGG--LARH--VPTH--- 
Q6Y8G5_HUMAN_121-143        FVC--NICGRAFTTKGN--LKVH--YMTH--- 
Q6Y8G6_HUMAN_461-483        FVC--NICGRAFTTKGN--LKVH--YMTH--- 
FOG1_HUMAN_320-342          FVC--LICLSAFTTKAN--CERH--LKVH--- 
O95276_HUMAN_92-114         FKC--LICNGAFTTGGS--LRRH--MGIH--- 
Q9NV14_HUMAN_160-185        FKCPALGCVRIFKRIGF--LNKHA-MTVH--- 
FOG2_HUMAN_363-385          FRCN--HCHFGFQTQRE--LLQHQ--ELH--- 
Q96IQ9_HUMAN_145-169        FRCSALSCTETFPSMQE--LVAHS--KLH--- 
Q9H0G6_HUMAN_31-55          FRCK--DCSAAYDTLVE--LTVHMNETGH--- 
Q9P254_HUMAN_212-236        FRCK--DCSAAYDTLVE--LTVHMNETGH--- 
Q63HK5_HUMAN_214-238        FRCK--DCSAAYDTLVE--LTVHMNETGH--- 
Q6N003_HUMAN_215-239        FRCR--QCSATYDTLVE--LTVHMNETGH--- 
Q8N260_HUMAN_215-239        FRCR--QCSAAYDTLVE--LTVHMNETGH--- 
Q8NDK8_HUMAN_284-306        FVCK--NCSQMFYTEKG--LSSHM--CFH--- 
Q9H0D2_HUMAN_284-306        FVCK--NCSQMFYTEKG--LSSHM--CFH--- 
Q7M4M3_HUMAN_77-99          FRCR--NCDEGFSYNYQ--LHTHM--SIH--- 
Q5R2W1_HUMAN_736-758        FICH--VCNKAFRTNFR--LWSHF--QSH--- 
Q5R2W1_HUMAN_842-864        FMCK--LCHRTFKTAFS--LWSHE--QTH--- 
Q6N003_HUMAN_926-948        FYCS--DCASQFRTPST--YISHL--ESH--- 
Q8N260_HUMAN_926-948        FYCS--DCASQFRTPST--YISHL--ESH--- 
Q69BM1_HUMAN_337-361        FECN--MCGYRSHDRYE--FSSHIARGEH--- 
Q69BM3_HUMAN_407-431        FECN--MCGYRSHDRYE--FSSHIARGEH--- 
Q9C0D4_HUMAN_982-1004       FKCW--FCGRLYEDQEE--WMSHGQR--H--- 
Q86X64_HUMAN_77-100         LKCP--VCSFVYGTKWE--FNRHLKN-KH--- 
Q9C0D4_HUMAN_108-130        FICS--HCSYISYTKGE--FQRHLV--KH--- 
                              *    *              :          
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Q9NWV2_HUMAN_81-103         FKCS--ICQRHFKNLKT--FVKHQQ--LH--- 
AIOL_HUMAN_174-196          FKC--HLCNYACQRRDA--LTGH--LRTH--- 
Q69BL7_HUMAN_174-196        FKC--HLCNYACQRRDA--LTGH--LRTH--- 
Q69BM3_HUMAN_140-162        FKC--HLCNYACQRRDA--LTGH--LRTH--- 
IKAR_HUMAN_173-195          FKC--HLCNYACRRRDA--LTGH--LRTH--- 
Q69BM4_HUMAN_173-195        FKC--HLCNYACRRRDA--LTGH--LRTH--- 
HELI_HUMAN_168-190          FKC--PFCSYACRRRDA--LTGH--LRTH--- 
Q6PQC6_HUMAN_142-164        FKC--PFCSYACRRRDA--LTGH--LRTH--- 
Q6PQC8_HUMAN_168-190        FKC--PFCSYACRRRDA--LTGH--LRTH--- 
Q6PQD0_HUMAN_142-164        FKC--PFCSYACRRRDA--LTGH--LRTH--- 
Q96JP3_HUMAN_175-197        FKC--PFCNYACRRRDA--LTGH--LRTH--- 
Q9H2S9_HUMAN_113-135        FKC--PFCNYACRRRDA--LTGH--LRTH--- 
Q71UL5_HUMAN_4-26           FEC--KLCHQRSRDYSA--MIKH--LRTH--- 
Q9Y2Y4_HUMAN_401-423        FSC--SLCPQRSRDFSA--MTKH--LRTH--- 
Q6ZMZ9_HUMAN_134-156        FEC--KVCGQAFRQRSA--LTVH--KQCH--- 
Q6ZTI2_HUMAN_93-117         FRCEFEGCERRFANSSD--RKKH--SHVH--- 
ZIC4_HUMAN_220-244          FRCEFEGCERRFANSSD--RKKH--SHVH--- 
ZIC1_HUMAN_332-356          FKCEFEGCDRRFANSSD--RKKH--MHVH--- 
Q96IQ9_HUMAN_176-198        FKC--ENCLLRFRTHRS--LFKH--LHVC--- 
Q6PIF0_HUMAN_243-265        FEC--PNCHERFARNST--LKCH--LTAC--- 
Q6DKI8_HUMAN_56-80          FECPVEGCCARFSARSS--LYIH--SKKH--- 
O95276_HUMAN_64-86          FKCSQ--CGRGFVSAGV--LKAH--IRTH--- 
PRDM6_HUMAN_542-564         FKCGY--CGRAFAGATT--LNNH--IRTH--- 
Q8WXE2_HUMAN_275-299        FVCPFQGCNRRFIQSNN--LKAH--ILTH--- 
Q96MM3_HUMAN_275-299        FVCPFQGCNRRFIQSNN--LKAH--ILTH--- 
PRD12_HUMAN_271-293         FVCRF--CNRRFSQSST--LRNH--VRLH--- 
Q96AM6_HUMAN_172-194        FICKF--CGRHFTKSYN--LLIH--ERTH--- 
Q96LB6_HUMAN_172-194        FICKF--CGRHFTKSYN--LLIH--ERTH--- 
Q8TAX0_HUMAN_175-197        FVCKF--CGRHFTKSYN--LLIH--ERTH--- 
ZIC1_HUMAN_302-326          FPCPFPGCGKVFARSEN--LKIH--KRTH--- 
ZIC4_HUMAN_190-214          FPCPFPGCGKVFARSEN--LKIH--KRTH--- 
Q6PJS0_HUMAN_212-234        FECKE--CGRSFRNSSC--LNDH--IQIH--- 
Q96MU6_HUMAN_365-387        FACVV--CGKYFRNSSC--LNNH--VRIH--- 
Q6ZS14_HUMAN_108-131        FQCKF--CVRYFRSKNL--LIEHT-RKVH--- 
Q7Z7H7_HUMAN_473-495        FECKD--CGETFNKSAA--LAEH--RKIH--- 
Q9BU03_HUMAN_71-93          FICFT--CARSFLSSKA--LITH--QRSH--- 
Q9H609_HUMAN_71-93          FICFT--CARSFPSSKA--LITH--QRSH--- 
Q6ZN24_HUMAN_186-208        IRCEF--CGEFFENRKG--LSSH--ARSH--- 
Q6ZN24_HUMAN_370-392        IRCEF--CGEFFENRKG--LSSH--ARSH--- 
Q7LDZ1_HUMAN_178-200        IRCEF--CGEFFENRKG--LSSH--ARSH--- 
Q7LDZ1_HUMAN_362-384        IRCEF--CGEFFENRKG--LSSH--ARSH--- 
Q7LDZ1_HUMAN_5-27           TTCEV--CGACFETRKG--LSSH--ARSH--- 
Q6ZN24_HUMAN_80-102         MRCDF--CGAGFDTRAG--LSSH--ARAH--- 
Q7Z6T2_HUMAN_769-793        FICEMPNCGAVFSSRQA--LNGH--ARIH--- 
Q9NUN9_HUMAN_99-123         FICEMPNCGAVFSSRQA--LNGH--ARIH--- 
Q9NQ73_HUMAN_769-793        FICEMPNCGAVFSSRQA--LNGH--ARIH--- 
Q96PN7_HUMAN_1013-1037      FICEMPNCGAVFSSRQA--LNGH--ARIH--- 
OVOL1_HUMAN_118-140         FTCRV--CQKAFTYQRM--LNRH-MKC-H--- 
Q86XL8_HUMAN_95-117         FTCRV--CQKAFTYQRM--LNRH-MKC-H--- 
Q5R2W1_HUMAN_708-731        WPCEK--CGKMFTVHKQ--LERH-QEL-LC-- 
Q6ZMW8_HUMAN_890-913        FICRK--CQMMFTDEDA--AVNH-QKS-FC-- 
Q5T149_HUMAN_335-357        FQCAL--CQKSFTQLAH--LQKH-HLV-H--- 
Q8IZ20_HUMAN_335-357        FQCAL--CQKSFTQLAH--LQKH-HLV-H--- 
Q5T149_HUMAN_411-433        FQCSV--CRSRFTQHIH--LKLH-HRL-H--- 
Q8IZ20_HUMAN_411-433        FQCSV--CRSRFTQHIH--LKLH-HRL-H--- 
Q9H9H3_HUMAN_125-147        FSCDI--CGKLFTRREH--VKRH-SLV-H--- 
                              *    *              :          
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ZBT10_HUMAN_726-748         FSCDI--CGKLFTRREH--VKRH-SLV-H--- 
Q6DKI8_HUMAN_26-50          FTCPVEGCGKSFTRAEH--LKGH-SIT-H--- 
Q6IPT8_HUMAN_399-421        FQCPT--CGVRFTRIQN--LKQH-MLI-H--- 
Q86VJ7_HUMAN_399-421        FQCPT--CGVRFTRIQN--LKQH-MLI-H--- 
Q86XX5_HUMAN_399-421        FQCPT--CGVRFTRIQN--LKQH-MLI-H--- 
Q86VJ7_HUMAN_427-449        FQCDR--CGKKFTRAYS--LKMH-RLK-H--- 
Q86XX5_HUMAN_427-449        FQCDR--CGKKFTRAYS--LKMH-RLK-H--- 
Q6IPT8_HUMAN_427-449        FQCDR--CGKKFTRAYS--LKMH-RLK-H--- 
ZSCA1_HUMAN_292-314         FQCAD--CGMVFTWVTH--FIEH-QKT-H--- 
ZSCA1_HUMAN_380-402         FQCSV--CGKAFPWMVH--LIDH-QKL-H--- 
Q8NDX6_HUMAN_129-151        FECDI--CDMRFIQKYH--LERH-KRV-H--- 
Q9NWV2_HUMAN_55-77          FECDV--CHKTFRQLVH--LERH-QLT-H--- 
Q9HD72_HUMAN_355-377        VACEI--CGKIFRDVYH--LNRH-KLS-H--- 
Q5TC79_HUMAN_429-452        FHCHV--CGKSFPFQAI--LNQH-FRKNH--- 
Q8WYT0_HUMAN_338-361        FHCHV--CGKSFPFQAI--LNQH-FRKNH--- 
Q5VYE9_HUMAN_432-455        FRCEI--CGKCFPFQGT--LNQH-LRKNH--- 
ZBT34_HUMAN_428-451         FRCEI--CGKCFPFQGT--LNQH-LRKNH--- 
Q8N8K7_HUMAN_426-448        FVCPY--CHKKFRRQAY--LRKH-LST-H--- 
Q96Q84_HUMAN_426-448        FVCPY--CHKKFRRQAY--LRKH-LST-H--- 
Q96T92_HUMAN_427-449        FVCPY--CHKKFRRQAY--LRKH-LST-H--- 
Q7M4M3_HUMAN_21-43          FSCEI--CEKKFYAMAH--VRKH-MVA-H--- 
Q9NZF0_HUMAN_20-42          YACRE--CGRTFRDRNS--LLKH--MIIH--- 
ZN644_HUMAN_448-470         YACRE--CGRTFRDRNS--LLKH--MIIH--- 
HKR2_HUMAN_31-53            YACQE--CGCTFSNNSS--LVKH--WHVH--- 
Q9BU03_HUMAN_143-165        FACTE--CGQDFAQEAG--LHQH--YIRH--- 
Q9H609_HUMAN_143-165        FACTE--CGQDFAQEAG--LHQH--YIRH--- 
O14860_HUMAN_13-35          FVCNE--CGKAFRDRPG--FIRH--YIIH--- 
Q7Z6T2_HUMAN_842-864        FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q7Z6T3_HUMAN_854-876        FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q9NUN9_HUMAN_172-194        FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q96PN7_HUMAN_1086-1108      FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q9NQ72_HUMAN_854-876        FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q9NQ73_HUMAN_842-864        FPCKE--CGKVFFKIKS--RNAH--MKTH--- 
Q8NDK8_HUMAN_477-499        FPCRE--CERVFDKIKS--RNAH--MKRH--- 
Q9H0D2_HUMAN_735-757        FPCRE--CERVFDKIKS--RNAH--MKRH--- 
ZSCA1_HUMAN_320-342         FPCPE--CGKVFLHNSV--LTEH--GKIH--- 
Q8WV14_HUMAN_211-233        FPCPE--CGMRFKRKFA--VEAH--QWIH--- 
Q9BU03_HUMAN_112-134        FPCPD--CGKTFGQAVS--LRRH--RQMH--- 
Q9H609_HUMAN_112-134        FPCPD--CGKTFGQAVS--LRRH--RQMH--- 
Q9HD72_HUMAN_292-314        LPCGL--CGKVFTDANR--LRQH--EAQH--- 
O14857_HUMAN_2-24           YVCT--ECERAFIRKSN--FITHQRIH----- 
Q7Z3Q9_HUMAN_133-155        HVCS--ECGKAFCYKSE--FIRHQRSH----- 
Q7Z7H7_HUMAN_420-442        YVCD--ECGRSFSVISE--FVEHQIMH----- 
PRDM7_HUMAN_346-368         YVCR--ECGEGFSRKSD--LLSHQRTH----- 
PRDM7_HUMAN_374-396         YVCR--ECERGFSRKSV--LLIHQRTH----- 
Q96AF5_HUMAN_332-354        YTCE--QCGRGFDWKSV--FVIHHRTH----- 
Q9UFF2_HUMAN_119-141        YTCE--QCGRGFDWKSV--FVIHHRTH----- 
ZN446_HUMAN_332-354         YTCE--QCGRGFDWKSV--FVIHHRTH----- 
Q9H686_HUMAN_229-251        YTCE--QCGRGFDWKSV--FVIHHRTH----- 
Q96AF5_HUMAN_395-417        YPCE--ECGCSFSWKSQ--LVIHRKSH----- 
Q9H686_HUMAN_292-314        YPCE--ECGCSFSWKSQ--LVIHRKSH----- 
Q9UFF2_HUMAN_182-204        YPCE--ECGCSFSWKSQ--LVIHRKSH----- 
ZN446_HUMAN_395-417         YPCE--ECGCSFSWKSQ--LVIHRKSH----- 
Q9UFF2_HUMAN_210-232        HFCS--DCGRAFDWKSQ--LVIHRKGH----- 
ZN446_HUMAN_423-445         HFCS--DCGRAFDWKSQ--LVIHRKGH----- 
Q9H686_HUMAN_320-342        HFCS--DCGRAFDWKSQ--LVIHRKGH----- 
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Q8N2J5_HUMAN_379-401        YKCP--ECDSSFSHKSS--LTKHQITH----- 
Q8N782_HUMAN_73-95          YECE--ECDKAFSFKSN--LESHRITH----- 
Q8N246_HUMAN_335-357        HECG--ECRKTFSYKSN--LIRHRRVH----- 
O14859_HUMAN_43-65          YKCK--QCGKGFSRRSA--VNVHCKVH----- 
ZNF27_HUMAN_1-23            FKCV--ECGKGFSRRSA--LNVHHKLH----- 
Q8N4W9_HUMAN_53-75          CKCH--QCGKVFSPRSL--LAEHEKIH----- 
ZNF18_HUMAN_29-51           CKCD--YCGKGFSDFSG--LRHHEKIH----- 
Q13580_HUMAN_30-52          YKCN--ECGKTFGQNSD--LLIHKSIH----- 
Q8N782_HUMAN_45-67          HKCN--ECGKTFSQKSY--LACHRSIH----- 
Q9H963_HUMAN_62-84          YKCN--QCGKTFSYKSS--LVIHKAIH----- 
ZNF79_HUMAN_70-92           YKCN--ECGKFFSESSA--LIRHHIIH----- 
O14889_HUMAN_12-34          YRCN--ECGKAFSVRSS--LTTHQAIH----- 
O43694_HUMAN_47-69          YQCH--ECRKPLVSVSS--LTTHQTIH----- 
Q15923_HUMAN_1-21           --CN--ECGKAFNQSAC--LMQHQRIH----- 
ZN253_HUMAN_200-222         YRCE--ECGKAFNQSAN--LTTHKRIH----- 
O14891_HUMAN_44-66          YRCE--ECGKAFGQSSS--LIHHQRIH----- 
Q96MU6_HUMAN_279-303        KPCELEECGKASPVSSS--LTQHVRIH----- 
Q15929_HUMAN_9-31           FKCI--VCGKAFNSSSN--LTTHKKIH----- 
ZN253_HUMAN_172-194         FKCI--ICGKAFKRSST--LTTHKKIH----- 
O43698_HUMAN_35-57          FKCE--ECGKAFNHPSA--LTTHKFIH----- 
O43698_HUMAN_63-85          YKCE--ECEKAFNRFSY--LTKHKIIH----- 
Q9H3U2_HUMAN_32-54          YKCE--ECGKAFNRFST--LTKHKRIH----- 
Q8N229_HUMAN_6-28           YKCE--ECGKAFSVFST--LTKHKIIH----- 
Q8N229_HUMAN_34-56          YKCE--ECGKAFNQSSI--FTKHKIIH----- 
ZNF15_HUMAN_29-51           YKCK--ECGKAFNQSST--LMKHKIIH----- 
ZN253_HUMAN_228-250         YKCE--ECGKAFNWSSD--LNKHKKIH----- 
Q9H3U2_HUMAN_4-26           YKCE--ECDRAFSQSSN--LTEHKKIH----- 
Q15929_HUMAN_37-59          YRCE--ECGKAFKRSSH--LTVHKIVH----- 
Q9H3U2_HUMAN_60-82          YKCE--ECGKAFNQSYQ--LTRHKIVH----- 
ZNF15_HUMAN_1-23            YKCE--ECGKSFILSSH--LTTHKIIH----- 
Q13580_HUMAN_2-24           YKCK--VCDKAFAWNSH--LVRHTRIH----- 
Q13580_HUMAN_86-108         YKCK--VCDKAFAWNSH--LVSHTSIH----- 
Q8N782_HUMAN_17-39          YKCE--ECDKAFRHNSA--LQRHRRIH----- 
ZNF27_HUMAN_29-51           YNCE--ECGKAFIHDSQ--LQEHQRIH----- 
Q7Z7K7_HUMAN_195-217        YKCK--ECGKAFHHFSY--LVKHQRIH----- 
Q8TBC5_HUMAN_413-435        YACG--ECGEAFAWLSH--LMEHHSSH----- 
Q9H9A0_HUMAN_413-435        YACG--ECGEAFAWLSH--LMEHHSSH----- 
Q9BRK7_HUMAN_310-332        YACG--ECGEAFAWLSH--LMEHHSSH----- 
O14860_HUMAN_44-66          IECI--ECGKAFNRRSY--RTWHQQRH----- 
Q8N2C6_HUMAN_45-67          YECV--ECGKAFNRRSP--LTRHQRIH----- 
O14852_HUMAN_2-24           HECN--QCGKAFNRSSN--HIHHQKVH----- 
Q16524_HUMAN_11-33          YECN--ACGEAFIRSKS--LARHQVLH----- 
Q16524_HUMAN_67-89          YECS--ECGKAFSRSKC--LIRHQSLH----- 
Q16524_HUMAN_39-61          YKCN--ACGRAFCSNRN--LIDHQRIH----- 
Q8N2C6_HUMAN_17-39          YVCI--QCGKAFCRTTN--LIRHFSIH----- 
Q15933_HUMAN_33-55          YECS--QCGKAFRQSTH--LTQHQRIH----- 
Q15936_HUMAN_39-61          YECS--QCGKAFRQSTH--LTQHQRIH----- 
O14885_HUMAN_33-55          YECH--QCGKAFSQRAH--LTIHQRIH----- 
Q8N8C0_HUMAN_33-55          YECQ--ICGKPFRKRAH--LTQHNRIH----- 
Q6ZMZ9_HUMAN_106-128        YECS--ECGKVIRRKAW--FDQHQRIH----- 
Q8N8C0_HUMAN_89-111         YECL--ECRKTFRRSAH--LIRHQRIH----- 
Q8N246_HUMAN_279-301        FECS--ECEESFSKKCH--LILHKIIH----- 
ZN212_HUMAN_455-477         YSCT--ECEKSFVQKQH--LLQHQKIH----- 
Q8N2J5_HUMAN_317-339        YECA--ECEISFRHKQQ--LTLHQRIH----- 
ZN212_HUMAN_316-338         YECS--ECEITFRYKQQ--LATHLRSH----- 
ZNF32_HUMAN_1-23            YECQ--ECGKSFRQKGS--LTLHERIH----- 
                              *    *              :          
54 
Q7Z7K7_HUMAN_279-301        YECK--ECGKSFTSGST--LNQHQQIH----- 
Q7Z7K7_HUMAN_307-329        YHCK--QCGKSFTVGST--LIRHQQIH----- 
Q8N246_HUMAN_251-273        YECS--KCEKAFTCKNT--LVQHQQIH----- 
O14861_HUMAN_41-63          YECT--ECGKSFSVKGK--LIQHQRIH----- 
ZN154_HUMAN_63-85           YECT--ECGKSFSHNSS--LIKHQRIH----- 
Q7Z3Q9_HUMAN_161-183        YGCT--DCGKAFSHKST--LIKHQRIH----- 
Q15933_HUMAN_61-83          YECN--DCGKAFSHSSS--LTKHQRIH----- 
Q15936_HUMAN_67-89          YECN--DCGNPFSHSSS--LTKHQRIH----- 
Q7KZ25_HUMAN_73-95          YVCN--DCGKAFSQSSS--LIYHQRIH----- 
ZK23_HUMAN_1-23             YECS--ECGKSFRQRSG--LIQHRRLH----- 
ZN154_HUMAN_35-57           YECS--ECGKSFTQNSG--LIKHRRVH----- 
ZK23_HUMAN_29-51            YECS--ECGKSFSQSAS--LIQHQRVH----- 
O14885_HUMAN_5-27           YECE--ECGKEFRHISS--LIAHQRMH----- 
ZN154_HUMAN_7-29            YECS--ECGKFFPYSSS--LRKHQRVH----- 
ZNF17_HUMAN_29-51           YECS--ECGKFFVDSCT--LKSHQRVH----- 
ZNF17_HUMAN_1-23            YECN--KCGKFFRYCFT--LNRHQRVH----- 
Q5T149_HUMAN_307-329        YECN--ICGKSFGQLSN--LKVHLRVH----- 
Q8IZ20_HUMAN_307-329        YECN--ICGKSFGQLSN--LKVHLRVH----- 
ZNF12_HUMAN_29-51           YECN--ECGKFFSRLSY--LTVHYRTH----- 
ZN126_HUMAN_29-51           YECN--QCGKAFSKHSH--LQCHKRTH----- 
ZN126_HUMAN_57-79           YECN--QCGKAFSQHGL--LQRHKRTH----- 
ZN126_HUMAN_1-23            YECN--QCGKAFAQHSS--LKCHYRTH----- 
O14892_HUMAN_1-21           --CP--ECGKSFCQKVT--STQHQRTH----- 
ZNF21_HUMAN_29-51           YACT--ECGKAFREKST--FTVHQRTH----- 
ZNF12_HUMAN_1-23            YKCS--ECGKCFCRKST--LTTHLRTH----- 
O14892_HUMAN_27-49          YECN--ACGKTFYHKSV--LTRHQIIH----- 
O14892_HUMAN_55-77          YECY--ECGKTFCLKSD--LTIHQRSH----- 
ZN174_HUMAN_354-376         YTCG--ECGNCFGRQST--LKLHQRIH----- 
Q5MPB1_HUMAN_54-76          YICE--ECGIRCKKPSM--LKKHIRTH----- 
Q82133_HUMAN_41-63          YICE--ECGIRCKKPSM--LKKHIRTH----- 
ZEP2_HUMAN_1186-1208        YICE--ECGIRCKKPSM--LKKHIRTH----- 
Q99302_HUMAN_3-25           YVCE--ECGIRCKKPSM--LKKHIRTH----- 
Q8N8C0_HUMAN_61-83          YECK--ECGKVFICCST--LIQHKRTH----- 
HKR2_HUMAN_59-81            YMCG--HCGKCFRESSS--LAKHQRVH----- 
ZN174_HUMAN_382-404         YQCG--QCGKSFRQSSN--LHQHHRLH----- 
ZBT12_HUMAN_387-409         HSCG--ICGKCFTQKST--LHDHLNLH----- 
Q8TAX0_HUMAN_231-253        FKCQ--ECGKGFCQSRT--LAVHKTLH----- 
Q96AM6_HUMAN_228-250        FKCQ--ECGKGFCQSRT--LAVHKTLH----- 
Q96LB6_HUMAN_228-250        FKCQ--ECGKGFCQSRT--LAVHKTLH----- 
Q9H963_HUMAN_34-56          YKCD--ICGKVFNQKRY--LAYHHRCH----- 
Q9H963_HUMAN_90-112         HKCN--ECGKVFNQKAY--FASHHRLH----- 
Q15921_HUMAN_36-58          YECE--ECGKSFSRSSH--LAQHQRTH----- 
Q96K08_HUMAN_183-205        YTCE--ECGKAFSRSSF--LVQHQRIH----- 
O14852_HUMAN_30-53          YTCV--ECGKAFSQSSH--LIQHQ-IHPH--- 
Q7KZ25_HUMAN_45-67          FKCD--ECGKGFVQGSH--LIQHQRIH----- 
ZN396_HUMAN_251-273         QKCD--ECGKIFSQSSA--LILHQRIH----- 
Q5U5Z4_HUMAN_242-264        FKCK--ECLKAFSQSSA--LIQHQRTH----- 
O14887_HUMAN_11-33          HTCD--ECGKSFCYISA--LHIHQRVH----- 
O14888_HUMAN_11-33          HTCD--ECGKSFCYISA--LHIHQRVH----- 
O14890_HUMAN_12-34          HTCD--ECGKSFCSISA--QHIHQRVH----- 
Q15921_HUMAN_8-30           HKCN--ECGKSFCRLSH--LIQHQRTH----- 
O14891_HUMAN_16-38          FKCI--ECGKAFRLSSK--LIQHQRIH----- 
Q6RFR8_HUMAN_138-160        HECM--ICGKAFRLHSH--LIQHQRIH----- 
Q8N4W9_HUMAN_25-47          HKCD--DCGKAFTSHSH--LVGHQRIH----- 
Q15923_HUMAN_27-49          YTCT--ECGKAFTQNSS--LVEHERTH----- 
ZNF26_HUMAN_29-51           FKCS--ECGKAFTQKSS--LSEHQRVH----- 
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Q15933_HUMAN_5-27           YGCN--ECGKTFSHSSS--LSQHERTH----- 
Q15936_HUMAN_11-33          YGCN--ECGKTFSHSSS--LSQHERTH----- 
Q96K08_HUMAN_155-177        WKCN--ECGKTFTQSSS--LTQHQRTH----- 
O14889_HUMAN_40-62          YKCN--ECGKVFTQNAH--LANHRRIH----- 
O43694_HUMAN_19-41          LLCH--ECGKVFTQNSH--LVRHRGIH----- 
Q92669_HUMAN_44-66          FTCH--ECGKKFSQNSH--LIKHRRTH----- 
O14857_HUMAN_30-52          YECS--DCGKSFTSKSQ--LLVHQPVH----- 
Z297B_HUMAN_373-394         YPC---QCGKSFTHKSQ--RDRHMSMH----- 
ZN174_HUMAN_326-348         YKCD--DCGKSFTWNSE--LKRHKRVH----- 
O14887_HUMAN_39-61          IKCD--VCGKEFSQSSH--LQTHQRVH----- 
O14890_HUMAN_40-62          YKCD--VCGKEFSQSSR--LQTHQRVH----- 
O14888_HUMAN_39-61          YKCY--VCGKEFSQSSH--LQTHQRVH----- 
O14859_HUMAN_15-37          LKCD--ECGKEFSQGAH--LQTHQKVH----- 
O14899_HUMAN_19-41          FKCE--ECGKEFSWSAG--LSAHQRVH----- 
Q9UFH1_HUMAN_26-48          YKCE--VCGKGFSQRSN--LQAHQRVH----- 
ZNF13_HUMAN_29-51           YKCE--ECGKGFSRASN--LLAHQRGH----- 
ZN229_HUMAN_377-399         YKCE--ECGKAFGRSSN--LLVHQRVH----- 
O14899_HUMAN_47-69          YTCQ--QCGKGFSQASH--FHTHQRVH----- 
O14899_HUMAN_75-97          YICD--VCCKGFSQRSH--LIYHQRVH----- 
Q9UFH1_HUMAN_54-76          YKCD--ACGKGFRWSSG--LLIHQRVH----- 
ZN229_HUMAN_349-371         YRCD--VCGKGFRYKSV--LLIHQGVH----- 
ZNF13_HUMAN_1-23            YQCD--ACGKGFSRSSD--FNIHFRVH----- 
GLIS1_HUMAN_322-346         YACQIPGCSKRYTDPSS--LRKHVKAH----- 
Q5VTL4_HUMAN_322-346        YACQIPGCSKRYTDPSS--LRKHVKAH----- 
GLIS3_HUMAN_471-495         YACQIPGCTKRYTDPSS--LRKHVKAH----- 
Q5VZV9_HUMAN_472-496        YACQIPGCTKRYTDPSS--LRKHVKAH----- 
Q9BZE0_HUMAN_293-317        YYCKMPGCHKRYTDPSS--LRKHIKAH----- 
Q6ZTI2_HUMAN_123-147        YTCKVRGCDKCYTHPSS--LRKHMKVH----- 
ZIC4_HUMAN_250-274          YTCKVRGCDKCYTHPSS--LRKHMKVH----- 
ZIC1_HUMAN_362-384          YLCKM--CDKSYTHPSS--VRKHMKVH----- 
Q5U5Z4_HUMAN_214-236        YKCST--CEKAFIHNSS--LRRHQKNH----- 
Q6ZN79_HUMAN_172-194        YQCNL--CEKAYTNCFR--LRRHKMTH----- 
Q6ZN79_HUMAN_200-222        YACHL--CGKAFTQCSH--LRRHEKTH----- 
Q8TBC5_HUMAN_441-463        YACQG--CWKTFHFSLA--LAEHQKTH----- 
Q9H9A0_HUMAN_441-463        YACQG--CWKTFHFSLA--LAEHQKTH----- 
Q9BRK7_HUMAN_338-360        YACQG--CWKTFHFSLA--LAEHQKTH----- 
Q96MU6_HUMAN_337-359        YECKD--CGKACGGFYL--LNEHGKTH----- 
Y0352_HUMAN_633-655         YQCKV--CHKFFRGRST--IKCHLKTH----- 
Q5U5Z4_HUMAN_270-292        YIC--KECGKAFSHSAS--LCKHLRTH----- 
ZN396_HUMAN_279-301         YAC--DECAKAFSRSAI--LIQHRRTH----- 
Q6PJS0_HUMAN_240-262        HKC--TYCGKAFTRSTQ--LTEHVRTH----- 
Q8NEI5_HUMAN_209-231        YTC--RYCGKIFPRSAN--LTRHLRTH----- 
Q6Q7C8_HUMAN_195-219        YLCDYPDCGKAFVQSGQ--LKTHQRLH----- 
Q7RTV3_HUMAN_195-219        YLCDYPDCGKAFVQSGQ--LKTHQRLH----- 
ZNF21_HUMAN_1-23            YEC--PVCWKAFSQKSQ--LIIHQRTH----- 
Q6ZN79_HUMAN_228-250        YKC--HQCGKAFIQSFN--LRRHERTH----- 
ZN396_HUMAN_307-329         YKC--HDCGKAFSQSSN--LFRHRKRH----- 
Q92669_HUMAN_16-38          YKC--SWCGKSFSQNTN--LHTHQRTH----- 
ZNF79_HUMAN_42-64           YKC--SECGKAFSQSTN--LIIHQKTH----- 
Q7KZ25_HUMAN_17-39          YKC--NKCTKAFGCSSR--LIRHQRTH----- 
Q8TB80_HUMAN_18-40          YSC--SACGKCFGGSGD--LRRHVRTH----- 
O14858_HUMAN_11-33          YECKQ--CSKAFPVYSS--YLRHEKIH----- 
O14858_HUMAN_39-61          YECKQ--CSKAFPDYSS--YLRHERTH----- 
Q15930_HUMAN_48-70          YECKE--CGKAFSSFKY--FCRHERTH----- 
Q8NAJ8_HUMAN_36-58          YECKQ--CGKAFVSFTS--FRYHERTH----- 
Q6RFS2_HUMAN_30-52          FECKR--CGKAFRSSSS--FRLHERTH----- 
                              *    *              :          
56 
Q8NAJ8_HUMAN_92-114         CECKK--CGKAFHNFSS--LQIHERMH----- 
Q15930_HUMAN_21-42          YKCK---CGKAFSDLFS--FQSHETTH----- 
Q6RFS2_HUMAN_58-80          YHCKE--CGKAYSCRAS--FQRHMLTH----- 
Q6LDH8_HUMAN_11-33          YECKQ--CGKLLSHRSS--FRRHMMAH----- 
Q6RFS2_HUMAN_2-24           YECKQ--CGKAFSYLNS--FRTHEMIH----- 
Q6RFR8_HUMAN_166-188        YECKE--CGKAFSYHSS--FSHHQRIH----- 
Q7M4M1_HUMAN_8-30           YECKE--CGKPFSFLTG--FRVHMRMH----- 
Q6Y8G5_HUMAN_93-115         HGCTR--CGKNFSSASA--LQIHERTH----- 
Q6Y8G6_HUMAN_433-455        HGCTR--CGKNXSXXSA--LQIHERTH----- 
Q6LDH8_HUMAN_39-61          HKCTV--CGKAFDSPSV--FQRHERTH----- 
GLIS1_HUMAN_262-286         NKCMFEGCSKAFSRLEN--LKIHLRSH----- 
Q5VTL4_HUMAN_262-286        NKCMFEGCSKAFSRLEN--LKIHLRSH----- 
GLIS3_HUMAN_411-435         NKCTFEGCEKAFSRLEN--LKIHLRSH----- 
Q5VZV9_HUMAN_412-436        NKCTFEGCEKAFSRLEN--LKIHLRSH----- 
Q9BZE0_HUMAN_235-257        HRCP--TCSKSFSRLEN--LKIHNRSH----- 
Q8N2J5_HUMAN_289-311        FTCM--ECGKSFRLKIN--LIIHQRNH----- 
ZNF32_HUMAN_29-51           FECT--HCGKSFRAKAN--LVTHQRIH----- 
Q8WXE2_HUMAN_245-269        FRCTFEGCGKRFSLDFN--LRTHVRIH----- 
Q96MM3_HUMAN_245-269        FRCTFEGCGKRFSLDFN--LRTHVRIH----- 
OVOL1_HUMAN_146-168         HLCTY--CGKGFNDTFD--LKRHVRTH----- 
Q86XL8_HUMAN_123-145        HLCTY--CEKGFNDTFD--LKRHVRTH----- 
O00110_HUMAN_125-147        HLCRC--CGKGFHDAFD--LKRHMRTH----- 
Q7Z5E7_HUMAN_74-96          HLCLY--CGKLYSRKYG--LKIHMRTH----- 
Q5XG86_HUMAN_438-460        YLCQQ--CGAAFAHNYD--LKNHMRVH----- 
ZBTB7_HUMAN_438-460         YLCQQ--CGAAFAHNYD--LKNHMRVH----- 
O73453_HUMAN_420-442        YLCIH--CNAKFVHNYD--LKNHMRIH----- 
Q5TC79_HUMAN_373-395        LTCIY--CAKSFNQKGS--LDRHMRLH----- 
Q8WYT0_HUMAN_282-304        LTCIY--CAKSFNQKGS--LDRHMRLH----- 
Q5VYE9_HUMAN_376-398        LICIY--CGKSFNQKGS--LDRHMRLH----- 
ZBT34_HUMAN_372-394         LICIY--CGKSFNQKGS--LDRHMRLH----- 
ZN212_HUMAN_427-449         LICGY--CGKSFSHPSD--LVRHQRIH----- 
BTEB1_HUMAN_143-167         HKCPYSGCGKVYGKSSH--LKAHYRV-H---- 
KLF13_HUMAN_167-191         HKCHYAGCEKVYGKSSH--LKAHLRT-H---- 
Q86TP0_HUMAN_199-223        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q8WWU2_HUMAN_319-343        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q8WWU4_HUMAN_553-577        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q8WWU3_HUMAN_336-360        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
SP3_HUMAN_621-645           HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q68DP2_HUMAN_11-35          HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q69B26_HUMAN_568-592        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
Q69B27_HUMAN_621-645        HICHIPGCGKVYGKTSH--LRAHLRW-H---- 
SP1_HUMAN_626-650           HICHIQGCGKVYGKTSH--LRAHLRW-H---- 
SP4_HUMAN_647-671           HICHIEGCGKVYGKTSH--LRAHLRW-H---- 
Q6BEB4_HUMAN_296-320        HVCHVPGCGKVYGKTSH--LKAHLRW-H---- 
Q6NTF6_HUMAN_294-318        HVCHVPGCGKVYGKTSH--LKAHLRW-H---- 
Q7Z615_HUMAN_356-380        HSCHIPGCGKVYGKTSH--LKAHLRW-H---- 
SP8_HUMAN_374-398           HSCHIPGCGKVYGKTSH--LKAHLRW-H---- 
Q7Z718_HUMAN_276-300        HSCHIPGCGKVYGKASH--LKAHLRW-H---- 
SP7_HUMAN_294-318           HSCHIPGCGKVYGKASH--LKAHLRW-H---- 
KLF10_HUMAN_369-393         HICSHPGCGKTYFKSSH--LKAHTRT-H---- 
O75411_HUMAN_358-382        HICSHPGCGKTYFKSSH--LKAHTRT-H---- 
KLF11_HUMAN_394-418         YVCSFPGCRKTYFKSSH--LKAHLRT-H---- 
KLF1_HUMAN_279-303          HTCAHPGCGKSYTKSSH--LKAHLRT-H---- 
Q6PIJ5_HUMAN_279-303        HTCAHPGCGKSYTKSSH--LKAHLRT-H---- 
KLF4_HUMAN_387-411          HTCDYAGCGKTYTKSSH--LKAHLRT-H---- 
Q8N717_HUMAN_421-445        HTCDYAGCGKTYTKSSH--LKAHLRT-H---- 
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Q5T3J9_HUMAN_346-370        HTCDYAGCGKTYTKSSH--LKAHLRT-H---- 
KLF2_HUMAN_272-296          HTCSYAGCGKTYTKSSH--LKAHLRT-H---- 
KLF12_HUMAN_317-341         HRCDFEGCNKVYTKSSH--LKAHRRT-H---- 
Q8WWI3_HUMAN_317-341        HRCDFEGCNKVYTKSSH--LKAHRRT-H---- 
KLF3_HUMAN_260-284          HRCDYDGCNKVYTKSSH--LKAHRRT-H---- 
Q6PIR1_HUMAN_260-284        HRCDYDGCNKVYTKSSH--LKAHRRT-H---- 
KLF5_HUMAN_373-397          HYCDYPGCTKVYTKSSH--LKAHLRT-H---- 
KLF8_HUMAN_274-298          HQCDFAGCSKVYTKSSH--LKAHRRI-H---- 
KLF6_HUMAN_200-224          HRCHFNGCRKVYTKSSH--LKAHQRT-H---- 
Q9BT79_HUMAN_200-224        HRCHFNGCRKVYTKSSH--LKAHQRT-H---- 
KLF7_HUMAN_219-243          HRCQFNGCRKVYTKSSH--LKAHQRT-H---- 
Q7Z3H8_HUMAN_186-210        HRCQFNGCRKVYTKSSH--LKAHQRT-H---- 
KLF15_HUMAN_321-345         HKCTFPGCSKMYTKSSH--LKAHLRR-H---- 
BTEB4_HUMAN_127-151         HRCPFPDCAKAYYKSSH--LKSHLRT-H---- 
KLF14_HUMAN_195-219         HQCPFPGCTKAYYKSSH--LKSHQRT-H---- 
O95276_HUMAN_36-58          YKCFY--CHRAYKKSCH--LKQHIRS-H---- 
Q86VQ7_HUMAN_283-307        YCCNYENCGKAYTKRSH--LVSHQRK-H---- 
Q8N805_HUMAN_283-307        YCCNYENCGKAYTKRSH--LVSHQRK-H---- 
Q5TC79_HUMAN_401-423        FVCRM--CGKKYTRKDQ--LEYHIRK-H---- 
Q8WYT0_HUMAN_310-332        FVCRM--CGKKYTRKDQ--LEYHIRK-H---- 
Q5VYE9_HUMAN_404-426        FVCKF--CGKKYTRKDQ--LEYHIRG-H---- 
ZBT34_HUMAN_400-422         FVCKF--CGKKYTRKDQ--LEYHIRG-H---- 
BTEB4_HUMAN_157-181         FACDWQGCDKKFARSDE--LARHHRT-H---- 
KLF13_HUMAN_197-221         FACSWQDCNKKFARSDE--LARHYRT-H---- 
KLF14_HUMAN_225-249         FSCDWLDCDKKFTRSDE--LARHYRT-H---- 
BTEB1_HUMAN_173-197         FPCTWPDCLKKFSRSDE--LTRHYRT-H---- 
KLF10_HUMAN_399-423         FSCSWKGCERRFARSDE--LSRHRRT-H---- 
O75411_HUMAN_388-412        FSCSWKGCERRFARSDE--LSRHRRT-H---- 
KLF11_HUMAN_424-448         FNCSWDGCDKKFARSDE--LSRHRRT-H---- 
KLF15_HUMAN_351-375         FACTWPGCGWRFSRSDE--LSRHRRS-H---- 
KLF12_HUMAN_347-371         YKCTWEGCTWKFARSDE--LTRHYRK-H---- 
Q8WWI3_HUMAN_347-371        YKCTWEGCTWKFARSDE--LTRHYRK-H---- 
KLF3_HUMAN_290-314          YKCTWEGCTWKFARSDE--LTRHFRK-H---- 
Q6PIR1_HUMAN_290-314        YKCTWEGCTWKFARSGE--LTRHFRK-H---- 
KLF8_HUMAN_304-328          YKCTWDGCSWKFARSDE--LTRHFRK-H---- 
KLF1_HUMAN_309-333          YACTWEGCGWRFARSDE--LTRHYRK-H---- 
Q6PIJ5_HUMAN_309-333        YACTWEGCGWRFARSDE--LTRHYRK-H---- 
KLF5_HUMAN_403-427          YKCTWEGCDWRFARSDE--LTRHYRK-H---- 
Q7Z3W8_HUMAN_5-29           YRCSWEGCEWRFARSDE--LTRHFRK-H---- 
Q9BT79_HUMAN_230-254        YRCSWEGCEWRFARSDE--LTRHFRK-H---- 
KLF6_HUMAN_230-254          YRCSWEGCEWRFARSDE--LTRHFRK-H---- 
KLF7_HUMAN_249-273          YKCSWEGCEWRFARSDE--LTRHYRK-H---- 
Q7Z3H8_HUMAN_216-240        YKCSWEGCEWRFARSDE--LTRHYRK-H---- 
Q5T3J9_HUMAN_376-400        YHCDWDGCGWKFARSDE--LTRHYRK-H---- 
Q8N717_HUMAN_451-475        YHCDWDGCGWKFARSDE--LTRHYRK-H---- 
KLF4_HUMAN_417-441          YHCDWDGCGWKFARSDE--LTRHYRK-H---- 
KLF2_HUMAN_302-326          YHCNWDGCGWKFARSDE--LTRHYRK-H---- 
Q68DP2_HUMAN_41-65          FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q69B26_HUMAN_598-622        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q69B27_HUMAN_651-675        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
SP3_HUMAN_651-675           FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q86TP0_HUMAN_229-253        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q8WWU2_HUMAN_349-373        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q8WWU3_HUMAN_366-390        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
Q8WWU4_HUMAN_583-607        FVCNWMYCGKRFTRSDE--LQRHRRT-H---- 
SP4_HUMAN_677-701           FICNWMFCGKRFTRSDE--LQRHRRT-H---- 
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Q6BEB4_HUMAN_326-350        FVCNWLFCGKSFTRSDE--LQRHLRT-H---- 
Q6NTF6_HUMAN_324-348        FVCNWLFCGKSFTRSDE--LQRHLRT-H---- 
Q7Z615_HUMAN_386-410        FVCNWLFCGKRFTRSDE--LQRHLRT-H---- 
SP8_HUMAN_404-428           FVCNWLFCGKRFTRSDE--LQRHLRT-H---- 
SP2_HUMAN_548-572           FVCNWFFCGKRFTRSDE--LQRHART-H---- 
Q7Z718_HUMAN_306-330        FVCNWLFCGKRFTRSDE--LERHVRT-H---- 
SP7_HUMAN_324-348           FVCNWLFCGKRFTRSDE--LERHVRT-H---- 
SP1_HUMAN_656-680           FMCTWSYCGKRFTRSDE--LQRHKRT-H---- 
EGR2_HUMAN_340-364          YPCPAEGCDRRFSRSDE--LTRHIRI-H---- 
Q68CZ5_HUMAN_340-364        YPCPAEGCDRRFSRSDE--LTRHIRI-H---- 
EGR3_HUMAN_275-299          HACPAEGCDRRFSRSDE--LTRHLRI-H---- 
EGR1_HUMAN_338-362          YACPVESCDRRFSRSDE--LTRHIRI-H---- 
EGR4_HUMAN_380-404          FACPVESCVRSFARSDE--LNRHLRI-H---- 
EGR2_HUMAN_398-420          FAC--DYCGRKFARSDE--RKRHTKI-H---- 
Q68CZ5_HUMAN_398-420        FAC--DYCGRKFARSDE--RKRHTKI-H---- 
EGR1_HUMAN_396-418          FAC--DICGRKFARSDE--RKRHTKI-H---- 
EGR3_HUMAN_333-355          FAC--EFCGRKFARSDE--RKRHAKI-H---- 
EGR4_HUMAN_438-460          FAC--DVCGRRFARSDE--KKRHSKV-H---- 
Q86VQ7_HUMAN_313-337        YSCNWESCSWSFFRSDE--LRRHMRV-H---- 
Q8N805_HUMAN_313-337        YSCNWESCSWSFFRSDE--LRRHMRV-H---- 
BTEB1_HUMAN_203-225         FRCP--LCEKRFMRSDH--LTKHARR-H---- 
KLF13_HUMAN_227-249         FSCP--ICEKRFMRSDH--LTKHARR-H---- 
KLF10_HUMAN_429-451         FACP--MCDRRFMRSDH--LTKHARR-H---- 
O75411_HUMAN_418-440        FACP--MCDRRFMRSDH--LTKHARR-H---- 
KLF11_HUMAN_454-476         FVCP--VCDRRFMRSDH--LTKHARR-H---- 
BTEB4_HUMAN_187-209         FSCP--LCSKRFTRSDH--LAKHARR-H---- 
KLF14_HUMAN_255-277         FSCP--LCPKQFSRSDH--LTKHARR-H---- 
Q7Z718_HUMAN_336-358        FTCL--LCSKRFTRSDH--LSKHQRT-H---- 
SP7_HUMAN_354-376           FTCL--LCSKRFTRSDH--LSKHQRT-H---- 
Q68DP2_HUMAN_71-93          FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q69B27_HUMAN_681-703        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q8WWU2_HUMAN_379-401        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q8WWU3_HUMAN_396-418        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q8WWU4_HUMAN_613-635        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
SP3_HUMAN_681-703           FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q69B26_HUMAN_628-650        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q86TP0_HUMAN_259-281        FVCP--ECSKRFMRSDH--LAKHIKT-H---- 
Q6BEB4_HUMAN_356-378        FACP--ECGKRFMRSDH--LAKHVKT-H---- 
Q6NTF6_HUMAN_354-376        FACP--ECGKRFMRSDH--LAKHVKT-H---- 
Q7Z615_HUMAN_416-438        FACP--VCNKRFMRSDH--LSKHVKT-H---- 
SP8_HUMAN_434-456           FACP--VCNKRFMRSDH--LSKHVKT-H---- 
SP1_HUMAN_686-708           FACP--ECPKRFMRSDH--LSKHIKT-H---- 
SP4_HUMAN_707-729           FECP--ECSKRFMRSDH--LSKHVKT-H---- 
SP2_HUMAN_578-600           FECA--QCQKRFMRSDH--LTKHYKT-H---- 
Q86VQ7_HUMAN_343-365        YKCD--QCSREFMRSDH--LKQHQKT-H---- 
Q8N805_HUMAN_343-365        YKCD--QCSREFMRSDH--LKQHQKT-H---- 
EGR2_HUMAN_370-392          FQCR--ICMRNFSRSDH--LTTHIRT-H---- 
Q68CZ5_HUMAN_370-392        FQCR--ICMRNFSRSDH--LTTHIRT-H---- 
EGR1_HUMAN_368-390          FQCR--ICMRNFSRSDH--LTTHIRT-H---- 
EGR3_HUMAN_305-327          FQCR--ICMRSFSRSDH--LTTHIRT-H---- 
EGR4_HUMAN_410-432          FQCR--ICLRNFSRSDH--LTSHVRT-H---- 
KLF12_HUMAN_377-399         FKCA--DCDRSFSRSDH--LALHRRR-H---- 
Q8WWI3_HUMAN_377-399        FKCA--DCDRSFSRSDH--LALHRRR-H---- 
KLF3_HUMAN_320-342          FQCP--DCDRSFSRSDH--LALHRKR-H---- 
Q6PIR1_HUMAN_320-342        FQCP--DCDRSFSRSDH--LALHRKR-H---- 
KLF8_HUMAN_334-356          FRCT--DCNRSFSRSDH--LSLHRRR-H---- 
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KLF1_HUMAN_339-361          FRCQ--LCPRAFSRSDH--LALHMKR-H---- 
Q6PIJ5_HUMAN_339-361        FRCQ--LCPRAFSRSDH--LALHMKR-H---- 
Q5T3J9_HUMAN_406-428        FQCQ--KCDRAFSRSDH--LALHMKR-H---- 
Q8N717_HUMAN_481-503        FQCQ--KCDRAFSRSDH--LALHMKR-H---- 
KLF4_HUMAN_447-469          FQCQ--KCDRAFSRSDH--LALHMKR-H---- 
KLF2_HUMAN_332-354          FQCH--LCDRAFSRSDH--LALHMKR-H---- 
KLF5_HUMAN_433-455          FQCG--VCNRSFSRSDH--LALHMKR-H---- 
KLF6_HUMAN_260-282          FKCS--HCDRCFSRSDH--LALHMKR-H---- 
Q7Z3W8_HUMAN_35-57          FKCS--HCDRCFSRSDH--LALHMKR-H---- 
KLF7_HUMAN_279-301          FKCN--HCDRCFSRSDH--LALHMKR-H---- 
Q7Z3H8_HUMAN_246-268        FKCN--HCDRCFSRSDH--LALHMKR-H---- 
Q5XG86_HUMAN_466-490        YQCD--SCCKTFVRSDH--LHRHLKK-DGC-- 
ZBTB7_HUMAN_466-490         YQCD--SCCKTFVRSDH--LHRHLKK-DGC-- 
O73453_HUMAN_448-472        YQCE--FCYKSFTRSDH--LHRHIKR-QSC-- 
KLF15_HUMAN_381-403         YQCP--VCEKKFARSDH--LSKHIKV-H---- 
Q8NDX6_HUMAN_157-179        YQCE--RCHQCFSRTDR--LLRHKRM-C---- 
Q8TB80_HUMAN_46-68          YTCE--ICNKCFTRSAV--LRRHKKM-H---- 
Q5XG86_HUMAN_410-432        YECN--ICKVRFTRQDK--LKVHMRK-H---- 
ZBTB7_HUMAN_410-432         YECN--ICKVRFTRQDK--LKVHMRK-H---- 
O73453_HUMAN_392-414        YMCT--ICEVRFTRQDK--LKIHMRK-H---- 
Z297B_HUMAN_428-450         YECN--ICAKRFMWRDS--FHRHVTS-C---- 
Q6ZN18_HUMAN_45-70          YNCCWDQCQACFNSSPD--LADHIRS-IH--- 
Q96BG3_HUMAN_53-78          YNCCWDQCQACFNSSPD--LADHIRS-IH--- 
Q8TAX0_HUMAN_203-225        YTC--DICHKAFRRQDH--LRDH-RY-IH--- 
Q96AM6_HUMAN_200-222        YTC--DICHKAFRRQDH--LRDH-RY-IH--- 
Q96LB6_HUMAN_200-222        YTC--DICHKAFRRQDH--LRDH-RY-IH--- 
Q8IUL5_HUMAN_310-333        YPC--QACGKRFSRLDH--LSSHFRT-IH--- 
Q8N2Y5_HUMAN_120-143        YPC--QACGKRFSRLDH--LSSHFRT-IH--- 
Q96BR9_HUMAN_310-333        YPC--QACGKRFSRLDH--LSSHFRT-IH--- 
Q96BX0_HUMAN_105-128        YPC--QACGKRFSRLDH--LSSHFRT-IH--- 
ZBTB8_HUMAN_369-392         YPC--ETCGKRFTRQEH--LRSHALS-VH--- 
GLIS1_HUMAN_292-316         YLCQHPGCQKAFSNSSD--RAKHQRT-H---- 
GLIS3_HUMAN_441-465         YLCQHPGCQKAFSNSSD--RAKHQRT-H---- 
Q5VTL4_HUMAN_292-316        YLCQHPGCQKAFSNSSD--RAKHQRT-H---- 
Q5VZV9_HUMAN_442-466        YLCQHPGCQKAFSNSSD--RAKHQRT-H---- 
Q9BZE0_HUMAN_263-287        YVCPYEGCNKRYSNSSD--RFKHTRT-H---- 
Q6N043_HUMAN_418-441        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
Q9H740_HUMAN_254-277        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
Q6MZM6_HUMAN_464-487        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
Q6N085_HUMAN_418-441        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
Q9HCI8_HUMAN_434-457        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
Q9NXS0_HUMAN_122-145        YVCQV--CNYRSSSFSD--VETHFRTSH---- 
ZNF18_HUMAN_1-23            FQCTI--CKKAFLRSSD--FVKHQRT-H---- 
Q6PIF0_HUMAN_215-237        HVCQY--CEKQFDHFGH--FKEHLRK-H---- 
Q6PIF0_HUMAN_279-301        YECQV--CNSVFNSWDQ--FKDHLVI-H---- 
Q9HD72_HUMAN_383-405        YSCPV--CGLRFKRKDR--MSYHVRS-H---- 
Q9Y2Y4_HUMAN_373-395        YACSV--CGKRFSLKHQ--METHYRV-H---- 
Y0352_HUMAN_605-627         YSCKV--CGKRFAHTSE--FNYHRRI-H---- 
O14861_HUMAN_13-35          YQCK--ECGKGFNNNTK--LIQHQRI-H---- 
Q6PJS0_HUMAN_128-150        YKCK--ECGKGFKYFAS--LDNHMGI-H---- 
Q5T967_HUMAN_241-263        FKCT--ECGKAFKYKHH--LKEHLRI-H---- 
Q9BYX9_HUMAN_4-26           YPCM--ICGKKFKSRGF--LKRHMKN-H---- 
Z297B_HUMAN_400-422         YGCG--VCGKKFKMKHH--LVGHMKI-H---- 
Q5T7W1_HUMAN_115-137        YECG--ICGKKYKYYNC--FQTHVRA-H---- 
Q5T7W2_HUMAN_115-137        YECG--ICGKKYKYYNC--FQTHVRA-H---- 
Q6ZT53_HUMAN_115-137        YECG--ICGKKYKYYNC--FQTHVRA-H---- 
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Q5T7W1_HUMAN_156-178        YTCD--ICGKKYKYYSC--FQEHRDL-H---- 
Q5T7W2_HUMAN_156-178        YTCD--ICGKKYKYYSC--FQEHRDL-H---- 
Q6ZT53_HUMAN_156-178        YTCD--ICGKKYKYYSC--FQEHRDL-H---- 
Q5T7W1_HUMAN_244-266        YTCE--FCGKQYKYYTP--YQEHVAL-H---- 
Q5T7W2_HUMAN_232-254        YTCE--FCGKQYKYYTP--YQEHVAL-H---- 
Q6ZT53_HUMAN_224-246        YTCE--FCGKQYKYYTP--YQEHVAL-H---- 
Q6ZMZ8_HUMAN_41-63          YKCD--QCGYLSKTANK--LIEHVRV-H---- 
Q8WXE2_HUMAN_217-239        HVCA--ECGKAFVESSK--LKRHFLVH----- 
Q96MM3_HUMAN_217-239        HVCA--ECGKAFVESSK--LKRHFLVH----- 
Q9NWV2_HUMAN_27-49          YVCN--ICFKHFETPSK--LARHYLIH----- 
ZN469_HUMAN_156-178         RDCH--HCGKRFPKPFK--LQRHLAVH----- 
ZBT12_HUMAN_359-381         FMCP--RCGKQFNHSSN--LNRHMNVH----- 
ZN580_HUMAN_120-142         FTCG--ACGKAFKRSSH--LSRHRATH----- 
Q658W5_HUMAN_197-219        YACH--LCGRRFTLRSS--LREHLQIH----- 
ZBTB2_HUMAN_254-276         YACH--LCGRRFTLRSS--LREHLQIH----- 
ZBT25_HUMAN_236-258         HLCH--YCGERFDSRSN--LRQHLHTH----- 
PRD12_HUMAN_243-265         MRCV--ICHRGFNSRSN--LRSHMRIH----- 
Q658W5_HUMAN_306-328        YECT--ICGRKFIQKSH--WREHMYIH----- 
ZBTB2_HUMAN_363-385         YECT--ICGRKFIQKSH--WREHMYIH----- 
ZBT25_HUMAN_347-369         MSCT--ICGHKFPRKSQ--LLEHMYTH----- 
Q8WV14_HUMAN_183-205        HVC--TDCGRRFTYPSL--LVSHRR-MH---- 
SP2_HUMAN_518-542           HVCHIPDCGKTFRKTSL--LRAHVR-LH---- 
O00110_HUMAN_192-214        HVC--EDCGFTSSRPDT--YAQHRA-LH---- 
ZFHX2_HUMAN_624-646         HTC--DQCAISFSSQDL--LTSHRR-LH---- 
ZN580_HUMAN_150-172         HTC--PLCPRRFQDAAE--LAQHVR-LH---- 
Q68DQ8_HUMAN_993-1016       FPC--RLCERSFCSAPS--LRRHVRVNH---- 
Q9H937_HUMAN_581-604        FPC--RLCERSFCSAPS--LRRHVRVNH---- 
Q5VWB8_HUMAN_581-604        FPC--RLCERSFCSAPS--LRRHVRVNH---- 
ZN592_HUMAN_1013-1036       YPC--RQCEQSFHTPNS--LRKHIRNNH---- 
Q9UPR8_HUMAN_711-734        YQC--KQCEESFHYKSQ--LRNHEREQH---- 
Q8NEI5_HUMAN_237-260        YRC--KYCDRSFSISSN--LQRHVRNIH---- 
PRDM6_HUMAN_514-536         YQC--GHCSQSFSQPSE--LRNHV-VTH---- 
Q8TBE5_HUMAN_138-161        YKC--ELCSFRCSDRSN--LSHHRRRKH---- 
Q9H5V7_HUMAN_138-161        YKC--ELCSFRCSDRSN--LSHHRRRKH---- 
Q9H2T0_HUMAN_138-161        YKC--ELCSFRCSDRSN--LSHHRRRKH---- 
Q9NZF0_HUMAN_158-181        YIC--KMCPFTTSAKSV--LKKHTEYLH---- 
ZN644_HUMAN_586-609         YIC--KMCPFTTSAKSV--LKKHTEYLH---- 
Q7Z5E7_HUMAN_102-124        LKC--KVCLRPFGDPSN--LNKHIR-LH---- 
Q5MPB1_HUMAN_82-106         YHCTY--CNFSFKTKGN--LTKHMKSKAH--- 
Q82133_HUMAN_69-93          YHCTY--CNFSFKTKGN--LTKHMKSKAH--- 
Q99302_HUMAN_31-55          YVCKH--CHFAFKTKGN--LTKHMKSKAH--- 
ZEP2_HUMAN_1214-1238        YVCKL--CNFAFKTKGN--LTKHMKSKAH--- 
Q9NV14_HUMAN_229-253        YFCLHFNCNESFKLPFQ--LAQHTKS--H--- 
ZN644_HUMAN_410-432         YPCTK--CNVNFREKKH--LHRHMMY--H--- 
Q63HK5_HUMAN_1041-1064      YQCKL--CNRTFASKHA--VKLHLSKT-H--- 
Q9H0G6_HUMAN_858-881        YQCKL--CNRTFASKHA--VKLHLSKT-H--- 
Q9P254_HUMAN_1039-1062      YQCKL--CNRTFASKHA--VKLHLSKT-H--- 
Q6DKI8_HUMAN_89-114         SRCPVSTCNRLFTSKHS--MKAHMVRQ-H--- 
ZBT12_HUMAN_415-438         YRCSY--CDVRFAHKPA--IRRHLKEQ-H--- 
Q6ZN29_HUMAN_3-26           YQCKK--CNVVFPRIFD--LITHQKKQ-C--- 
Q9UBK3_HUMAN_85-108         YRCED--CDQLFESKAE--LADHQKFP-C--- 
Q5VWB8_HUMAN_415-437        YKCAM--CDTVFTHKPL--LSSHFDQH----- 
Q9H937_HUMAN_415-437        YKCAM--CDTVFTHKPL--LSSHFDQH----- 
Q68DQ8_HUMAN_827-849        YKCAM--CDTVFTHKPL--LSSHFDQH----- 
Q8N8K7_HUMAN_291-313        YRCPE--CDKVFSCPAN--LASHRRWH----- 
Q96T92_HUMAN_292-314        YRCPE--CDKVFSCPAN--LASHRRWH----- 
                              *    *              :          
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Q96Q84_HUMAN_291-313        YRCPE--CDKVFSCPAN--LASHRRWH----- 
ZN580_HUMAN_92-114          YSCPE--CARVFASPLR--LQSHRVSH----- 
Q96JV0_HUMAN_737-759        YQCKH--CDSKLQSTAE--LTSHLNIH----- 
Q96JV0_HUMAN_896-918        YHCSQ--CDRVLMSMQG--LRSHERSH----- 
Q6Q7C8_HUMAN_167-189        IRCNI--CNRVFPREKS--LQAHKRTH----- 
Q7RTV3_HUMAN_167-189        IRCNI--CNRVFPREKS--LQAHKRTH----- 
ZNF26_HUMAN_1-23            YECNE--CEKAYPRKAS--LQIHQKTH----- 
Q71UL5_HUMAN_32-54          YQCTI--CTEYCPSLSS--MQKHMKGH----- 
Q9Y2Y4_HUMAN_428-450        YRCSL--CGAGCPSLAS--MQAHMRGH----- 
Q6ZN29_HUMAN_184-206        YQCDQ--CTVAFPTLEL--WQEHQHVH----- 
FOG1_HUMAN_290-314          RVCPFPQCRKSCPSASS--LEIHMRS--H--- 
FOG2_HUMAN_296-320          SLCPFPQCTKSFSNARA--LEMHLNS--H--- 
Q6ZMW8_HUMAN_162-185        KRCPF--CRALFKAKSA--LESHIRSR-H--- 
Q6ZN29_HUMAN_366-389        KRCPF--CRALFKAKSA--LESHIRSR-H--- 
Q8TBE5_HUMAN_110-132        HRCHL--CPFASAYERH--LEAHMRS--H--- 
Q9H2T0_HUMAN_110-132        HRCHL--CPFASAYERH--LEAHMRS--H--- 
Q9H5V7_HUMAN_110-132        HRCHL--CPFASAYERH--LEAHMRS--H--- 
POGZ_HUMAN_494-516          FRCPH--CTKRLKNNIR--FMNHMKH--H--- 
Q5SZS4_HUMAN_494-516        FRCPH--CTKRLKNNIR--FMNHMKH--H--- 
Q5SZS3_HUMAN_439-461        FRCPH--CTKRLKNNIR--FMNHMKH--H--- 
Q5SZS1_HUMAN_399-421        FRCPH--CTKRLKNNIR--FMNHMKH--H--- 
Q5SZS2_HUMAN_441-463        FRCPH--CTKRLKNNIR--FMNHMKH--H--- 
Q9UPR8_HUMAN_683-705        YQCPI--CEHIADNSKD--LESHMIH--H--- 
POGZ_HUMAN_619-641          LLCPY--CLKVFKNGNA--FQQHYMR--H--- 
Q5SZS1_HUMAN_524-546        LLCPY--CLKVFKNGNA--FQQHYMR--H--- 
Q5SZS2_HUMAN_575-597        LLCPY--CLKVFKNGNA--FQQHYMR--H--- 
Q5SZS3_HUMAN_564-586        LLCPY--CLKVFKNGNA--FQQHYMR--H--- 
Q5SZS4_HUMAN_619-641        LLCPY--CLKVFKNGNA--FQQHYMR--H--- 
Q7Z6T2_HUMAN_351-373        LTCSI--CLKEFKNLPA--LNGHMRS--H--- 
Q7Z6T3_HUMAN_351-373        LTCSI--CLKEFKNLPA--LNGHMRS--H--- 
Q9NQ73_HUMAN_351-373        LTCSI--CLKEFKNLPA--LNGHMRS--H--- 
Q9NQ72_HUMAN_351-373        LTCSI--CLKEFKNLPA--LNGHMRS--H--- 
Q96PN7_HUMAN_512-534        LTCSI--CLKEFKNLPA--LNGHMRS--H--- 
Q9H0G6_HUMAN_92-116         LKCMY--CGHSFESLQD--LSVHMIKTKH--- 
Q9P254_HUMAN_273-297        LKCMY--CGHSFESLQD--LSVHMIKTKH--- 
Q63HK5_HUMAN_275-299        LKCMY--CGHSFESLQD--LSVHMIKTKH--- 
Q96MY0_HUMAN_186-208        LKCSI--CGHLFSSCSD--LEKHAES--H--- 
Q9UBK3_HUMAN_139-161        QECKE--CDQVFPDLQS--LEKHMLS--H--- 
Y0352_HUMAN_508-530         FSCSV--CANSFVDWHL--LEKHMAV--H--- 
AIOL_HUMAN_202-224          YKCE--FCGRSYKQRSS--LEEHKER-C---- 
Q69BM1_HUMAN_59-81          YKCE--FCGRSYKQRSS--LEEHKER-C---- 
Q69BL7_HUMAN_202-224        YKCE--FCGRSYKQRSS--LEEHKER-C---- 
HELI_HUMAN_196-219          HKCN--YCGRSYKQRSS--LEEHKER-CH--- 
Q6PQC8_HUMAN_196-219        HKCN--YCGRSYKQRSS--LEEHKER-CH--- 
Q6PQD0_HUMAN_170-193        HKCN--YCGRSYKQRSS--LEEHKER-CH--- 
IKAR_HUMAN_201-224          HKCG--YCGRSYKQRSS--LEEHKER-CH--- 
Q96JP3_HUMAN_208-231        YKCN--YCGRSYKQQST--LEEHKER-CH--- 
Q9H2S9_HUMAN_146-169        YKCN--YCGRSYKQQST--LEEHKER-CH--- 
Q6ZN20_HUMAN_244-267        LKCP--KCNWHYKYQQT--LEAHMKE-KH--- 
ZN409_HUMAN_453-476         LKCP--KCNWHYKYQQT--LDVHMQE-KH--- 
Q5T967_HUMAN_171-194        LTCP--YCDRGYKRFTS--LKEHIKY-RH--- 
Q8IUL5_HUMAN_282-304        FKCP--YCTHVVKRKAD--LKRHLR--CH--- 
Q8N2Y5_HUMAN_92-114         FKCP--YCTHVVKRKAD--LKRHLR--CH--- 
Q96BR9_HUMAN_282-304        FKCP--YCTHVVKRKAD--LKRHLR--CH--- 
Q96BX0_HUMAN_77-99          FKCP--YCTHVVKRKAD--LKRHLR--CH--- 
Q9H9H3_HUMAN_97-119         LKCP--HCSYVAKYRRT--LKRHLL--IH--- 
                              *    *              :          
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ZBT10_HUMAN_698-720         LKCP--HCSYVAKYRRT--LKRHLL--IH--- 
ZBTB8_HUMAN_341-363         HKCP--FCPYTAKQKGI--LKRHIR--SH--- 
ZFHX2_HUMAN_103-127         FKCT--VCRVSYNQSST--LEIHMRSVLH--- 
ZFHX2_HUMAN_46-70           YKCT--VCKESFTQKNI--LLVHYNSVSH--- 
PRD12_HUMAN_299-323         YKCQ--VCQSAYSQLAG--LRAHQKSARH--- 
Q6ZN20_HUMAN_299-323        FRCE--VCNYSTTTKGN--LSIHMQSDKH--- 
ZN409_HUMAN_508-532         YRCD--VCNYSTTTKGN--LSIHMQSDKH--- 
Q6ZN20_HUMAN_367-391        WRCE--VCDYETNVARN--LRIHMTSEKH--- 
Q9BYX9_HUMAN_35-57          YRCT--DCDYTTNKKIS--LHNHLES--H--- 
Q6ZS14_HUMAN_600-623        YKCT--MCNYSTTTLKG--LRVHQQH-KH--- 
Q9UPR8_HUMAN_655-677        YRCR--LCHYTSGN-KG--YIKQHLR-VH--- 
Q5T1J7_HUMAN_442-465        VFCN--ACGK-TFYDKG-TLKIHYNA-VH--- 
Q8NAR2_HUMAN_13-36          VFCN--ACGK-TFYDKG-TLKIHYNA-VH--- 
Q6T3A3_HUMAN_363-386        VFCN--ACGK-TFYDKG-TLKIHYNA-VH--- 
Q6ZN30_HUMAN_441-464        VFCN--ACGK-TFYDKG-TLKIHYNA-VH--- 
BNC1_HUMAN_357-380          VFCT--ACEK-TFYDKG-TLKIHYNA-VH--- 
Q6T3A3_HUMAN_957-980        IMCN--ICHK-MYSNKG-TLRVHYKT-VH--- 
Q9NXV0_HUMAN_325-348        IMCN--ICHK-MYSNKG-TLRVHYKT-VH--- 
Q9H6J0_HUMAN_251-274        IMCN--ICHK-MYSNKG-TLRVHYKT-VH--- 
Q6ZN30_HUMAN_1035-1058      IMCN--ICHK-MYSNKG-TLRVHYKT-VH--- 
BNC1_HUMAN_928-951          ITCH--LCQK-TYSNKG-TFRAHYKT-VH--- 
Q5T1J7_HUMAN_834-857        KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
Q9NXV0_HUMAN_123-146        KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
Q6T3A3_HUMAN_755-778        KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
Q6ZN30_HUMAN_833-856        KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
Q8NAR2_HUMAN_405-428        KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
Q9H6J0_HUMAN_49-72          KICY--VCKK-SFKSSY-SVKLHYRN-VH--- 
BNC1_HUMAN_720-743          FQCD--ICKK-TFKNAC-SVKIHHKN-MH--- 
Q9C0D4_HUMAN_136-159        YQCE--YCDYGAIRNDY-IVK-HTKR-VH--- 
OVOL1_HUMAN_174-197         YKCS--LCDK-AFTQRC-SLESHLKK-IH--- 
Q86XL8_HUMAN_151-174        YKCS--LCDK-AFTQRC-SLESHLKK-IH--- 
O00110_HUMAN_153-176        FRCS--ACGK-AFTQRC-SLEAHLAK-VH--- 
Q7M4M1_HUMAN_36-59          YKCK--DCGN-AFIWRA-SLQYHVKK-VH--- 
Q7Z5E7_HUMAN_131-154        YRCE--FCGK-VLVRRR-DLERHVKS-RH--- 
Q96MY0_HUMAN_528-551        CACT--DCGQ-VATNRT-DLEIHVKR-CH--- 
FOG1_HUMAN_241-264          FPCK--DCGIWYRSERN--LQAHLLY-YC--- 
ZN592_HUMAN_1153-1176       AQCL--LCGLCYTSASS--LSRHLFI-VH--- 
Q86XK6_HUMAN_120-143        FTCH--HCGKQLRSLAG--MKYHVMA-NH--- 
ZN512_HUMAN_197-220         FTCH--HCGKQLRSLAG--MKYHVMA-NH--- 
Q86XK6_HUMAN_210-233        LKCH--HCGKPYRSKAG--LAYHLRS-EH--- 
ZN512_HUMAN_287-310         LKCH--HCGKPYRSKAG--LAYHLRS-EH--- 
Q86XK6_HUMAN_363-386        YKCL--LCQKEFVSESG--VKYHINS-VH--- 
ZN512_HUMAN_440-463         YKCL--LCQKEFVSESG--VKYHINS-VH--- 
Q8N8K7_HUMAN_525-548        FSCK--HCPSTFFSSPG--LTRHINK-CH--- 
Q96Q84_HUMAN_525-548        FSCK--HCPSTFFSSPG--LTRHINK-CH--- 
Q96T92_HUMAN_526-549        FSCK--HCPSTFFSSPG--LTRHINK-CH--- 
Q96MY0_HUMAN_705-728        FQCK--KCFYKTRSSTV--LTRHIKL-RH--- 
Q8NDX6_HUMAN_101-123        FVCE--HCFGAFRSSYH--LKRHIL--IH--- 
Q96JV0_HUMAN_959-982        FRCK--LC--SFKSSYNSRLKTHILK-AH--- 




Appendix B – Consensus Output 
 
Target GD-AA : Template specified/identified is 1AAY Chain A 
 
Columns 1-2 correspond to the target. 
Columns 3-4 correspond to the template. 
Column 5 is the confidence (0-9) for that pair of aligned residues according to sequence 
alignments 
Column 6 is the selection status. 
       An 'S' indicates that the corresponding pair of residues has been confidently aligned 
       and may be used in homology modeling. 
       A '.' indicates otherwise. 
Please disregard column 7. This is only for diagnostic purposes and will soon be removed. 
 
 
 ---------  GD-AA.consensus --------- 
 
R 3     R 1     9       .       H 
P 4     P 2     9       . 
Y 5     Y 3     9       . 
A 6     A 4     9       . 
C 7     C 5     9       . 
P 8     P 6     9       . 
V 9     V 7     9       . 
E 10    E 8     6       . 
S 11    S 9     7       S       D 
C 12    C 10    9       S       D 
D 13    D 11    9       S       D 
R 14    R 12    9       S       D 
R 15    R 13    9       S       D 
F 16    F 14    9       S       D 
S 17    S 15    9       S       D 
Q 18    R 16    9       S       D 
K 19    S 17    9       S       D 
T 20    D 18    9       S       D 
N 21    E 19    9       S       A 
L 22    L 20    9       S       A 
D 23    T 21    9       S       E 
T 24    R 22    9       S       E 
H 25    H 23    9       S       AE 
I 26    I 24    9       S       AE 
R 27    R 25    9       S       AE 
I 28    I 26    9       S       E 
H 29    H 27    9       S       E 
T 30    T 28    9       S       E 
G 31    G 29    9       S       E 
Q 32    Q 30    9       S       E 
K 33    K 31    9       S       E 
P 34    P 32    9       S       E 
F 35    F 33    9       S       E 
Q 36    Q 34    9       S       E 
C 37    C 35    9       S       E 
R 38    R 36    9       S       E 
I 39    I 37    9       S       E 
C 40    C 38    9       S       E 
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M 41    M 39    9       S       E 
R 42    R 40    9       S       E 
N 43    N 41    9       S       E 
F 44    F 42    9       S       AE 
S 45    S 43    9       S       AE 
Q 46    R 44    9       S       E 
H 47    S 45    9       S       E 
T 48    D 46    9       S       E 
G 49    H 47    9       .       G 
L 50    L 48    9       .       DG 
N 51    T 49    9       .       DG 
Q 52    T 50    9       .       AG 
H 53    H 51    9       .       AG 
I 54    I 52    9       .       EG 
R 55    R 53    9       .       EG 
T 56    T 54    9       .       EG 
H 57    H 55    9       .       EG 
T 58    T 56    9       .       EG 
G 59    G 57    9       .       EG 
E 60    E 58    9       .       EG 
K 61    K 59    9       .       EG 
P 62    P 60    9       .       EG 
F 63    F 61    9       .       EG 
A 64    A 62    9       .       EG 
C 65    C 63    9       .       EG 
D 66    D 64    9       .       EG 
I 67    I 65    9       .       EG 
C 68    C 66    9       .       EG 
G 69    G 67    9       .       EG 
R 70    R 68    9       .       EG 
K 71    K 69    9       .       EG 
F 72    F 70    9       .       AEG 
A 73    A 71    9       .       AEG 
T 74    R 72    9       .       EG 
L 75    S 73    9       .       EG 
H 76    D 74    9       .       EG 
T 77    E 75    9       .       EG 
R 78    R 76    9       .       EGI 
D 79    K 77    9       .       EGI 
R 80    R 78    9       .       EGI 
H 81    H 79    9       .       EGI 
T 82    T 80    9       .       EGI 
K 83    K 81    9       .       EGI 
I 84    I 82    9       .       EGI 
H 85    H 83    9       .       EGI 
L 86    L 84    9       .       EGI 
R 87    R 85    9       .       EGI 
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Target 1AAY : Template specified/identified is 1G2D Chain C 
 
Columns 1-2 correspond to the target. 
Columns 3-4 correspond to the template. 
Column 5 is the confidence (0-9) for that pair of aligned residues according to sequence 
alignments 
Column 6 is the selection status. 
       An 'S' indicates that the corresponding pair of residues has been confidently aligned 
       and may be used in homology modeling. 
       A '.' indicates otherwise. 
Please disregard column 7. This is only for diagnostic purposes and will soon be removed. 
 
 ---------  AA-GD.consensus --------- 
 
M 1     M 1     5       .       H 
E 2     E 2     7       .       DH 
R 3     R 3     9       .       DH 
P 4     P 4     9       S       D 
Y 5     Y 5     9       S       D 
A 6     A 6     9       S       D 
C 7     C 7     9       S       D 
P 8     P 8     9       S       D 
V 9     V 9     9       S       D 
E 10    E 10    9       S       D 
S 11    S 11    9       S       D 
C 12    C 12    9       S       D 
D 13    D 13    9       S       D 
R 14    R 14    9       S       D 
R 15    R 15    9       S       D 
F 16    F 16    9       S       D 
S 17    S 17    9       S       D 
R 18    Q 18    9       S       D 
S 19    K 19    9       S       D 
D 20    T 20    9       S       D 
E 21    N 21    9       S       D 
L 22    L 22    9       S       D 
T 23    D 23    9       S       D 
R 24    T 24    9       S       A 
H 25    H 25    9       S       A 
I 26    I 26    9       S       A 
R 27    R 27    9       S       A 
I 28    I 28    9       S       E 
H 29    H 29    9       S       E 
T 30    T 30    9       S       E 
G 31    G 31    9       S       E 
Q 32    Q 32    9       S       E 
K 33    K 33    9       S       E 
P 34    P 34    9       S       E 
F 35    F 35    9       S       E 
Q 36    Q 36    9       S       E 
C 37    C 37    9       S       E 
R 38    R 38    9       S       E 
I 39    I 39    9       S       E 
C 40    C 40    9       S       E 
M 41    M 41    9       S       E 
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R 42    R 42    9       S       E 
N 43    N 43    9       S       E 
F 44    F 44    9       S       AE 
S 45    S 45    9       S       AE 
R 46    Q 46    9       S       E 
S 47    H 47    9       S       E 
D 48    T 48    9       S       E 
H 49    G 49    9       S       A 
L 50    L 50    9       S       A 
T 51    N 51    9       S       E 
T 52    Q 52    9       S       E 
H 53    H 53    9       S       E 
I 54    I 54    9       S       E 
R 55    R 55    9       S       E 
T 56    T 56    9       S       E 
H 57    H 57    9       S       E 
T 58    T 58    9       S       E 
G 59    G 59    9       S       E 
E 60    E 60    9       S       E 
K 61    K 61    9       S       E 
P 62    P 62    9       S       E 
F 63    F 63    9       S       E 
A 64    A 64    9       S       E 
C 65    C 65    9       S       E 
D 66    D 66    9       S       E 
I 67    I 67    9       S       E 
C 68    C 68    9       S       E 
G 69    G 69    9       S       E 
R 70    R 70    9       S       E 
K 71    K 71    9       S       E 
F 72    F 72    9       S       AE 
A 73    A 73    9       S       AE 
R 74    T 74    9       S       AE 
S 75    L 75    9       S       E 
D 76    H 76    9       S       E 
E 77    T 77    9       S       E 
R 78    R 78    9       S       E 
K 79    D 79    9       .       EI 
R 80    R 80    9       .       EI 
H 81    H 81    9       .       AEI 
T 82    T 82    9       .       AEI 
K 83    K 83    9       .       EI 
I 84    I 84    9       .       EI 
H 85    H 85    9       .       EI 
L 86    L 86    9       .       EI 
R 87    R 87    9       .       EI 
Q 88    Q 88    9       .       EI 
K 89    K 89    9       .       EI 
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Target ME-AA : Template specified/identified is 1AAY Chain A 
 
Columns 1-2 correspond to the target. 
Columns 3-4 correspond to the template. 
Column 5 is the confidence (0-9) for that pair of aligned residues according to sequence 
alignments 
Column 6 is the selection status. 
       An 'S' indicates that the corresponding pair of residues has been confidently aligned 
       and may be used in homology modeling. 
       A '.' indicates otherwise. 
Please disregard column 7. This is only for diagnostic purposes and will soon be removed. 
 
 
 ---------  ME-AA.consensus --------- 
 
K 3     R 1     9       .       F 
P 4     P 2     9       .       F 
Y 5     Y 3     9       .       F 
K 6     A 4     9       .       F 
C 7     C 5     9       .       F 
P 8     P 6     9       .       F 
E 9     V 7     7       .       F 
C 10    C 10    9       .       F 
G 11    D 11    9       .       F 
K 12    R 12    9       S       D 
S 13    R 13    9       S       D 
F 14    F 14    9       S       D 
S 15    S 15    9       S       D 
Q 16    R 16    9       S       D 
S 17    S 17    9       S       D 
S 18    D 18    9       S       D 
N 19    E 19    9       S       A 
L 20    L 20    9       S       A 
Q 21    T 21    9       S       E 
K 22    R 22    9       S       E 
H 23    H 23    9       S       AE 
Q 24    I 24    9       S       AE 
R 25    R 25    9       S       AE 
T 26    I 26    9       S       E 
H 27    H 27    9       S       E 
T 28    T 28    9       S       E 
G 29    G 29    9       S       E 
E 30    Q 30    9       S       E 
K 31    K 31    9       S       E 
P 32    P 32    9       S       E 
Y 33    F 33    9       S       E 
K 34    Q 34    9       S       E 
C 35    C 35    9       S       E 
P 36    R 36    9       S       E 
E 37    I 37    9       S       E 
C 38    C 38    9       S       E 
G 39    M 39    9       . 
K 40    R 40    9       S       D 
S 41    N 41    9       S       D 
F 42    F 42    9       S       A 
68 
S 43    S 43    9       S       A 
Q 44    R 44    9       S       E 
S 45    S 45    9       S       E 
S 46    D 46    9       S       E 
D 47    H 47    9       S       E 
L 48    L 48    9       S       E 
Q 49    T 49    9       S       E 
K 50    T 50    9       S       AE 
H 51    H 51    9       S       AE 
Q 52    I 52    9       S       E 
R 53    R 53    9       S       E 
T 54    T 54    9       S       E 
H 55    H 55    9       S       E 
T 56    T 56    9       S       E 
G 57    G 57    9       S       E 
E 58    E 58    9       S       E 
K 59    K 59    9       S       E 
P 60    P 60    9       S       E 
Y 61    F 61    9       S       E 
K 62    A 62    9       S       E 
C 63    C 63    9       S       E 
P 64    D 64    9       S       E 
E 65    I 65    9       S       E 
C 66    C 66    9       S       E 
G 67    G 67    9       S       E 
K 68    R 68    9       S       E 
S 69    K 69    9       S       E 
F 70    F 70    9       S       AE 
S 71    A 71    9       S       AE 
R 72    R 72    9       S       E 
S 73    S 73    9       S       E 
D 74    D 74    9       S       E 
H 75    E 75    9       S       E 
L 76    R 76    9       .       EI 
S 77    K 77    9       .       EI 
R 78    R 78    9       .       EI 
H 79    H 79    9       .       EI 
Q 80    T 80    9       .       EI 
R 81    K 81    9       .       EI 
T 82    I 82    9       .       EI 
H 83    H 83    9       .       EI 
Q 84    L 84    9       .       EI 
N 85    R 85    9       .       EI 
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Appendix C – Domain Information for Each Homology Modeled EGR Protein 
 






AA-GD Domain 1 (Residues 1 – 32) 
RPYACPVESCDRRFSRSDELTRHIRIHTGQKP 
 
AA-GD Domain 2 (Residues 30 – 60)  
QKPFQCRICMRNFSRSDHLTTHIRTHTGEKP 
 










GD-AA Domain 1 (Residues 1 – 34) 
MERPYACPVESCDRRFSQKTNLDTHIRIHTGQKP 
 
GD-AA Domain 2 (Residues 32 – 61) 
QKPFQCRICMRNFSQHTGLNQHIRTHTGEK 
 










GD-AA Domain 1 (Residues 1 – 30) 
KPYKCPECGKSFSQSSNLQKHQRTHTGEKP 
 
ME-AA Domain 2 (Residues 28 – 58) 
EKPYKCPECGKSFSQSSDLQKHQRTHTGEKP 
 




Appendix D – RMS versus Crystal Structure for Clustered Models 
 









Time (ps) RMS 
1 R 870 0.77 44 R 2970 2.3 
2 P 485 0.82 45 S 1560 2.05 
3 Y 2752.5 1.45 46 D 1557.5 1.27 
4 A 3470 0.63 47 H 1087.5 0.82 
5 C 1095 0.94 48 L 1037.5 0.47 
6 P 1767.5 1.67 49 T 385 0.88 
7 V 1555 1.01 50 T 837.5 0.67 
8 E 1625 2.61 51 H 3847.5 1.52 
9 S 1542.5 2.95 52 I 2415 0.57 
10 C 280 2.05 53 R 1245 0.66 
11 D 3592.5 2.48 54 T 1817.5 1.04 
12 R 3400 3.04 55 H 2265 1.7 
13 R 1600 0.66 56 T 1237.5 0.39 
14 F 3425 1.72 57 G 317.5 0.29 
15 S 1517.5 0.95 58 E 2300 1.74 
16 R 3102.5 1.13 59 K 3112.5 0.65 
17 S 2672.5 0.64 60 P 3182.5 0.41 
18 D 1442.5 2.06 61 F 795 1.46 
19 E 237.5 0.97 62 A 317.5 0.14 
20 L 1115 0.57 63 C 2592.5 0.87 
21 T 1090 1.18 64 D 1055 2.44 
22 R 910 2.43 65 I 2675 1.09 
23 H 882.5 1.77 66 C 1410 0.84 
24 I 3047.5 1.85 67 G 3040 0.25 
25 R 2610 1.76 68 R 830 3.68 
26 I 1897.5 2.13 69 K 1265 1.23 
27 H 2850 1.27 70 F 3562.5 1.5 
28 T 837.5 335 71 A 2205 0.31 
29 G 3010 0.87 72 R 3402.5 1.39 
30 Q 3132.5 2.65 73 S 3367.5 0.33 
31 K 3177.5 3.53 74 D 2490 1.91 
32 P 2622.5 0.58 75 E 2592.5 1.07 
33 F 3887.5 1.61 76 R 3342.5 2.14 
34 Q 607.5 0.77 77 K 860 2.07 
35 C 3927.5 0.9 78 R 1415 1.55 
36 R 2102.5 4.02 79 H 1117.5 1.25 
37 I 2365 0.94 80 T 1515 1.0 
38 C 2437.5 0.49 81 K 3647.5 2.27 
39 M 2717.5 0.51 82 I 3400 0.51 
40 R 547.5 4.9 83 H 655 2.84 
41 N 2235 0.49 84 L 272.5 1.17 
42 F 200 0.46 85 R 1062.5 2.55 













Time (ps) RMS 
1 M 2410 1.3 45 S 525 0.84 
2 E 460 2.74 46 Q 1120 0.97 
3 R 3970 2.27 47 H 2235 0.87 
4 P 2622.5 0.61 48 T 1080 1.16 
5 Y 3580 1.49 49 G 2622.5 0.25 
6 A 317.5 0.25 50 L 3827.5 0.6 
7 C 2432.5 0.45 51 N 305 1.02 
8 P 3597.5 1439.5 52 Q 1352.5 0.84 
9 V 2622.5 0.41 53 H 1320 1.23 
10 E 3105 2.73 54 I 1082.5 1.59 
11 S 3760 0.98 55 R 3207.5 2.21 
12 C 325 1.26 56 T 3087.5 2.07 
13 D 890 1.47 57 H 3302.5 1.18 
14 R 2645 1.92 58 T 1805 0.32 
15 R 1107.5 1.63 59 G 1465 0.16 
16 F 525 1.47 60 E 1200 1.52 
17 S 1030 0.68 61 K 640 0.61 
18 Q 377.5 0.86 62 P 3467.5 0.48 
19 K 1097.5 1.34 63 F 2010 1.57 
20 T 317.5 1.22 64 A 2622.5 0.49 
21 N 3382.5 1.14 65 C 485 0.95 
22 L 940 0.28 66 D 2325 0.92 
23 D 3225 1.91 67 I 992.5 1.12 
24 T 1680 0.75 68 C 2010 0.49 
25 H 2105 0.64 69 G 2683.5 0.54 
26 I 3972.5 1.54 70 R 2620 1.04 
27 R 1837.5 1.13 71 K 1622.5 1.71 
28 I 1350 0.68 72 F 1222.5 1.56 
29 H 2285 1.24 73 A 2622.5 0.15 
30 T 3507.5 0.29 74 T 2927.5 0.39 
31 G 3207.5 0.15 75 L 3757.5 0.7 
32 Q 1377.5 0.83 76 H 3087.5 1.36 
33 K 2982.5 0.32 77 T 2820 0.71 
34 P 317.5 0.32 78 R 1817.5 1.61 
35 F 3660 1.56 79 D 862.5 1.96 
36 Q 2680 0.38 80 R 1287.5 3.62 
37 C 1820 1.08 81 H 1072.5 0.99 
38 R 3945 2.19 82 T 3252.5 0.91 
39 I 2137.5 0.87 83 K 2417.5 1.72 
40 C 815 0.91 84 I 1045 0.65 
41 M 2342.5 0.79 85 H 1665 2.8 
42 R 2140 5.41 86 L 2012.5 1.07 
43 N 2625 1.12 87 R 2017.5 3.46 
44 F 3955 0.7 88 Q 2225 0.93 
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Time (ps) RMS 
1 K 3617.5 1.78 42 Q 1320 0.71 
2 P 3702.5 0.55 43 S 1707.5 0.33 
3 Y 1537.5 1.71 44 S 417.5 0.51 
4 K 2650 0.94 45 D 3735 1.07 
5 C 2385 0.5 46 L 2090 0.5 
6 P 392.5 0.57 47 Q 1307.5 1.97 
7 E 1435 2.12 48 K 957.5 2.4 
8 C 3412.5 1.25 49 H 1412.5 0.79 
9 G 532.5 0.67 50 Q 1592.5 0.76 
10 K 1640 0.59 51 R 1710 2.28 
11 S 992.5 0.75 52 T 2560 0.46 
12 F 1135 1.45 53 H 1665 2.22 
13 S 322.5 0.82 54 T 2622.5 0.56 
14 Q 735 1.18 55 G 860 0.39 
15 S 600 0.48 56 E 1752.5 2.14 
16 S 1665 0.66 57 K 2640 2.56 
17 N 2420 1.11 58 P 1732.5 0.35 
18 L 3112.5 0.46 59 Y 3780 1.49 
19 Q 2910 0.76 60 K 1090 1.86 
20 K 3075 2.21 61 C 1707.5 0.6 
21 H 2597.5 0.66 62 P 2187.5 0.61 
22 Q 2297.5 1.04 63 E 3995 2.49 
23 R 3812.5 2.01 64 C 2287.5 0.98 
24 T 3247.5 0.46 65 G 3007.5 0.25 
25 H 1170 2.3 66 K 817.5 0.71 
26 T 1995 0.37 67 S 620 0.47 
27 G 482.5 0.21 68 F 3277.5 1.46 
28 E 3640 1.98 69 S 2882.5 0.45 
29 K 2115 1.1 70 R 2680 1.98 
30 P 1400 0.47 71 S 1120 0.44 
31 Y 1105 0.66 72 D 2455 0.55 
32 K 402.5 3.06 73 H 2262.5 2.08 
33 C 3605 0.64 74 L 3957.5 0.51 
34 P 1960 0.42 75 S 2935 0.84 
35 E 2465 2.86 76 R 2005 4.51 
36 C 1627.5 0.62 77 H 1265 0.93 
37 G 2260 0.22 78 Q 2327.5 0.69 
38 K 2097.5 1.81 79 R 2650 4.92 
39 S 2397.5 0.9 80 T 1457.5 1.52 
40 F 2985 0.95 81 H 660 1.88 
41 S 922.5 0.79  
 
